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Abstract 
Background 
There is global recognition of the need for early identification of those at risk of malnutrition.  
Nutritional screening has been advocated for systematically detecting and managing those at 
nutritional risk, triggering a dietetic referral where indicated.  Dietetic assessment aims to 
minimise progression to overt malnutrition and ultimately, curtail the associated clinical and 
financial consequences.  Patients receiving haemodialysis treatment are at increased risk of 
malnutrition.  Generic nutritional screening tools are inherently limited in this population due to 
the observed variances in fluid status.  There is currently no validated nutritional screening tool 
that is effective in this population.    
Study aim  
The present study aimed to test the effectiveness of the Leeds Nutritional Screening Tool 
(developed through pilot studies) in 140 representative haemodialysis patients.   
Methodology 
By means of a clinical audit, the clinical support worker tested the Leeds tool and the dietitian 
provided the criterion measure.  A distinct feature was the inclusion of patients that were unable to 
fully complete answers, due to dementia, learning difficulties and a language barrier.  
Findings 
Risk of malnutrition was evident in 49% of the Leeds sample.  The Leeds tool showed good 
diagnostic accuracy (95%) with sensitivity and specificity comparable with other National Health 
Service tests.  In turn, these results suggest that patients would be appropriately signposted for 
dietetic assessment, without wasting finite resources.  Component analysis showed that the tool 
was well-balanced with a combination of objective and subjective measures and that it could be 
simplified by removal of a question on appetite, without affecting performance.  Reliability testing 
was achieved by patient self-completion and by a nurse, both of whom produced consistent results 
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with the clinical support worker.  The tool was evaluated to have good practical acceptability 
amongst users.  
Conclusions 
This research suggests that the Leeds tool can identify patients at risk of malnutrition, fulfilling the 
requirements needed to consider local implementation, alongside appropriate staff education.  This 
research provide a sound framework for the development and testing of nutritional screening tools, 
in a field of variable study quality.  It is hoped that the results will contribute to the wider 
audience, with further research needed to assess tool transferability amongst dialysis units. 
Keywords: haemodialysis, nutritional screening, malnutrition 
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Glossary of terms  
Terminology                            Meaning 
Albumin A protein in the blood which has many important roles, including 
keeping fluid from leaking out of blood vessels into the tissues 
Anorexia A decreased sensation of appetite leading to a poor nutritional status 
Anthropometry 
/Anthropometric 
Physical measurements of body size, proportions and functional capacity 
that can be used to interpret nutritional status 
Assessment Detailed evaluation of information, with the purpose of informing a 
conclusion   
BMI Body mass index, a weight for height numerical measurement used to 
determine whether a patient is a healthy weight  
Cardiovascular disease A disease that affects the heart and blood vessels 
Clinical outcome Measurable changes in health 
Catabolism Degradation of complex material to release energy 
Co-morbidity More than two diseases occurring in the same person 
Criterion measure The most superior measure available, which provides as the benchmark 
Deficiency Insufficiency of something ie. a nutrient 
Dependent variable The effect or outcome that is measured 
Diagnosis/diagnostic Identification of a condition 
Dialysis vintage Period of time since commencing dialysis 
Dietitian A registered expert in the field of human nutrition 
Dietetic assessment Completion of detailed evaluation of nutritional measures by a dietitian 
Dietetic clinical 
judgement 
The balance and interpretation of the information gained from a dietetic 
assessment by a dietitian 
End stage renal failure The failure of the kidneys to function normally, as a result of differing 
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causes.  Dialysis or transplant is required to sustain life 
Gastrointestinal The digestive system related to the stomach and the intestine, that is 
involved in consuming, digesting, absorbing and expelling nutrients 
Haemodialysis A medical treatment for end stage renal failure, using a haemodialysis 
machine to clean the blood of toxins and surplus fluid  
Hypermetabolism An increased rate of activity within the body 
Immune function The body’s defence system against disease and infection 
Independent variable The items being changed, which may effect the dependent variable 
Inflammation The body’s response at a cellular level in trying to protect against 
infection and to initiate the healing process 
Malnutrition A condition resulting from eating too little or too much of certain 
nutrients,  with adverse clinical outcome attached 
Metabolic disturbance 
/derangement  
 
Where the body’s internal environment is unstable  
Multi-disciplinary A team of health professionals, which can comprise of doctors, nurses, 
dietitians, pharmacists, physiotherapists 
Nutritional indices 
/markers 
Measures that in combination can be used to determine nutritional status 
 
Nutritional intervention 
 
 
A care plan aimed at helping to improve the nutrition related problem 
Nutritional screening A series of questions that are simple and quick to complete by a nurse or 
a clinical support worker to identify the risk of malnutrition  
Nutritional screening 
tool 
 
The framework of questions or variables asked during nutritional 
screening, which has a care plan that contains different dietary 
recommendations (including a referral to the dietitian where indicated)  
Objective An item that is measured within distinct categories, that has boundaries 
and is not influenced by opinion 
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Pathogenesis The process that causes the disease 
Reliable or reliability Consistent results when completed by others 
Renal The kidney system which controls toxins, PH and fluid status 
Sensitivity The ability of the test to correctly identify disease 
Subjective Based on opinion, not specific measurements 
Subjective global 
assessment 
An assessment tool that uses several objective and subjective nutrition 
related parameters to aid evaluation of malnutrition risk  
Specificity The ability of a test to correctly identify there is no disease 
Target weight The goal weight for the end of dialysis, at which the body is thought to 
be at normal fluid balance 
The UK Renal 
Association 
The UK expert panel of renal doctors and scientists  
Transferability The extension of findings for transfer to another context or setting 
Uraemic The build-up of urea in the blood, as the kidneys are failing and this can 
cause nausea, vomiting and taste changes 
Valid/validity The measure is well-founded and measures what it is supposed to 
Variable A determinant or an item that is thought to be of importance 
Variance A measure of the variation 
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Malnutrition; can the Leeds screening tool identify haemodialysis patients at risk? 
1.1 Defining malnutrition 
As a result of the complex nature of malnutrition there is no universally accepted 
definition, despite its prevalence as a public health concern.  The British Association of Enteral 
and Parenteral Nutrition (BAPEN) offer suggested terminology for malnutrition (as 
undernutrition) as “…a state of nutrition in which a deficiency…of energy, protein and other 
nutrients causes measurable adverse effects on tissue/body form (body shape, size and 
composition) and function and clinical outcome.” (2003, p.8). 
          Without a consensus on definition, agreed diagnostic criteria for malnutrition and 
those at risk of malnutrition are also lacking, including anthropometric, biochemical and clinical 
indices (Kovesdy & Kalantar-Zadeh, 2012).  Three core nutritional risk variables that contribute to 
the identification of malnutrition risk have been recognised (BAPEN, 2000; National Institute for 
Health and Clinical Excellence [NICE], 2006).  These centre on body weight; a weight for height 
measure (Body Mass Index, [BMI]) and a calculated percentage of unintentional weight loss and 
also dietary intake (DI).  Specialist dietetians are required to quantify and assess the functional, 
medical and nutritional measures to determine risk of malnutrition and in turn put treatment plans 
in place. 
Despite the complexities of defining and diagnosing malnutrition, the adverse effects of 
malnutrition on ‘every system and tissue of the body’ (NICE 2006, p.54) are well documented.  
These may include altered physiological and psychological responses, such as; diminished 
immune function, impaired wound healing, organ dysfunction, metabolic disturbances and altered 
mental states (BAPEN, 2000; NICE, 2006).  Malnutrition can cause ill-health and also be a 
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consequence of it (BAPEN, 2003).  In practice there is a vicious circle, Figure 1.1, whereby ill-
health can fuel nutritional depletion, which exacerbates and prolongs the clinical condition. 
 
Figure 1.1 Relationship between nutritional status and ill-health 
1.2 The cost of malnutrition 
Over 3 million patients in the United Kingdom (UK) are estimated to be at risk of 
malnutrition (BAPEN, 2009), costing over 10% of national health expenditure (BAPEN, 2005, 
p.34), at £13 billion per annum (BAPEN, 2009, p.2).  As the risk of malnutrition and clinical 
adversity progresses (described in Figure 1.1) predictably, so do the financial penalties.  BAPEN 
(2005, p.22) estimate that patients at medium and high risk of malnutrition cost healthcare 
resources nearly double that of those at low risk (a difference of over £1,500 per annum per 
patient).  Lim et al. (2012) extends clinical concern, demonstrating a four-fold increased risk of 
mortality at 1 year (p<.001) in malnourished patients, as diagnosed by an expert dietitian.  A 
proactive, co-ordinated and timely approach for identifying, managing and monitoring the 
endemic problem of malnutrition is therefore of paramount importance to reduce patient, medical 
and financial burden (NICE, 2006). 
1.3 A way forward 
Increased risk of 
malnutrition
Weakened 
body 
defences 
and bodily 
systems
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worsening 
condition
Disease related 
appetite loss, 
altered 
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Screening is an integral process in the National Health Service (NHS) for the evaluation of 
many medical parameters (such as risk of fever, falls and dementia).  Screening involves the 
nursing staff (N/S) or the clinical support worker (CSW) to complete a series of quick and simple 
questions relating to clinical risk variables for the systematic detection of those at risk 
(Arrowsmith 1999; Ferguson, Capra, Bauer, & Banks, 1999).  The associated scoring system can 
then facilitate the action required and direct finite resources appropriately (Bennett et al., 2012).  
The identification, management and monitoring of those at risk of malnutrition through nutritional 
screening (NS) and associated care plans, seen in Figure 1.2, are supported by an abundance of 
UK government standards and specialist groups (British Dietetic Association [BDA], 1999; 
Kondrup, Allison, Elia, Vellas & Plauth 2003; NICE, 2006).   
 
 
 
Nutritional 
screening 
NST; example risk 
variables 
 BMI 
Unintentional weight 
loss 
Food intake 
Identified risk 
level based on the 
scoring system 
Low  
Medium  
or High 
Nutritional care 
plan dependent 
on score 
1. Monitor 
2. Simple dietary 
measures 
3.If indicated 
dietetic referral 
 
Figure 1.2 Nutritional screening overview 
Nutritional care has been identified as potentially the fourth biggest NHS cost saving 
(BAPEN, 2010, p.3), with an effective NST being at the very core of this. Unfortunately there is 
not one specific nutritional screening tool (NST) that is valid in all patient groups (BDA, 1999; 
Van Bokhorst, Guaitolo, Jansma & Vet, 2013).   
1.4 End Stage Renal Failure 
Perhaps the strongest argument for NS is within patients with chronic conditions, such as 
those with end stage renal failure (ESRF), where malnutrition is described as ‘one of the most 
prevalent complications’ (Yamada et al., 2008, p.106).  Upto 40% of patients receiving 
haemodialysis (HD) treatment are at risk of malnutrition according to the UK ESRF specialist 
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body (The UK Renal Association [RA], 2010), which is extended to 75%, by the expert European 
consensus panel (Fouque et al., 2008, p.392).  With the acknowledgement that the HD population 
is currently over 23,000, increasing by 2.3% since 2011, the scale of concern can be appreciated 
(RA, 2013). 
As a result of declining kidney function leading to ESRF, the patient requires HD to clean 
the blood of unwanted toxins, to help restore normal fluid balance and to correct metabolic 
disturbances.  The patient needs to attend the dialysis unit three times a week for this to happen. 
The altered metabolic processes and symptoms associated with HD, along with elevated 
nutritional requirements make this a nutritionally fragile population.  
The consequences of malnutrition-related clinical sequelae in ESRF mirror those seen in 
the general population, as concluded by multiple authors (Kidney Disease Outcomes Quality 
Initiative [KDOQI], 2000; Kovesdy & Kalantar-Zadeh, 2012).  Lawson, J., Lazarus & Kelly 
(2001), for example found that malnourished patients with ESRF had increased hospital 
admissions (23%) over 12 months (p .001).  Likewise, de Mutsert et al. (2009) noted malnutrition 
as an independent predictor of morbidity and mortality within their large ESRF sample (n=1601) 
of malnourished patients, reporting a dose dependent relationship with severity of malnutrition.   
Nationally, RA (2010) and internationally, KDOQI (2000), support NS throughout the 
course of HD, for the identification of those needing dietetic assessment.  There is currently no 
validated NST for the HD population (KDOQI, 2000; RA, 2010).  Generic NSTs have a reduced 
diagnostic accuracy in patients with altered fluid balance, such as those with ESRF (RA, 2010).  
This is because fluid can bias the interpretation of core nutritional indices which NSTs rely upon 
(such as weight, weight loss and BMI) (Visser, Dekker, Boeschoten, Stevens, & Kredict, 1999).   
1.5 Summary 
This section has endeavoured to identify the serious issue of malnutrition and the 
importance of early screening with prompt dietary management, in an attempt to reduce the 
possibility of malnutrition, manage resources and improve clinical outcomes.  HD patients are at 
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an increased likelihood of experiencing malnutrition and the Leeds Teaching Hospital Trust 
(LTHT) has identified the need for an effective NST, driven by NICE, (2006) and RA (2010).  
Consequently, the Leeds Nutritional Screening Tool (LST) has been developed and piloted (see 
Appendix 1, 2).  
Primary study aim 
The primary aim of this audit was to test whether the senstivity of the LST is consistent with 
dietetic clinical judgement in identifying HD patients at risk of malnutrition. 
 
The literature review 
At the outset of this chapter the complex pathogenesis of malnutrition in ESRF will be 
outlined, alongside observed rates of risk of malnutrition.  The requirements of an effective NST 
will be detailed, setting the context of this study.  Two tools will be presented as examples; 
Malnutrition Universal Screening Tool (MUST) and the Subjective Global Assessment (SGA).  
This literature review will consider important data relating to the testing of these tools, focusing 
on UK and European studies.  Despite the wealth of information within the field of malnutrition, 
the specific aspect of malnutrition within HD has been relatively overlooked.  Nonetheless, 
lessons can be drawn from the content and testing of these tools, which has informed this research 
(Appendix 2).    
2.1 Pathogenesis of malnutrition in the HD population 
Malnutrition within the HD population is due to a complex interplay of disease and non-
disease specific risk variables, with the underlying principles illustrated in Figure 2.1. 
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Figure 2.1. Pathogenesis of malnutrition in HD (with permission from Carrero et al., 2013, p.78) 
The identified risk variables in ERSF, in Figure 2.1, provide a literary framework for 
research into the effect of each determinant on progressive anorexia, which are detailed under two 
main processes; increased nutritional requirements and reduced DI. 
2.1.1 Increased nutritional requirements.  The following information describes at the 
metabolic level how HD treatment predisposes patients to malnutrition.   
Dialysis associated catabolism.  Although relatively unexplored, the relevance of dialysis 
associated losses are identified by Neyra et al. (2003) stating that energy expediture increases upto 
20% (cited by Carrero et al., 2013).  Furthermore, Ikizler and Hakim (1996) report a two-fold 
increase in protein requirements due to HD, although this work is nearly two decades old it 
remains consistent with current therapeutic guidelines (BDA, 2011).  Water soluble vitamin losses 
are also evident (RA, 2010). 
Metabolic derangements.  ESRF is associated with inflammation, hypermetabolism and 
hormonal derangements and consequently, protein catabolism is induced, heightening nutritional 
needs (Stenvinkel, Heimburger, Lindholm, Kaysen & Berdstrom, 2000).  
2.1.2 Reduced DI.  Malnutrition risk is heightened due to HD related effects on DI.  
Lawson, J. et al. (2001) linked necessary dietary potassium and protein restriction with 
malnutrition, however they failed to see similar trends with other dietary restrictions and this may 
be due to a limited sample size (n=50).  Confusion over dietary restrictions and patient over-
restriction can also limit DI in practice.     
Loss of kidney function and Uraemic toxins.  The importance of effective dialysis, to 
remove toxins and excess fluid is demonstrated by Galland et al. (2001), whereby on receiving 
good dialysis there was an increased intake of 13% and 24% in energy and protein (cited by 
Locatelli et al., 2002).  Due to the effects of HD, about 60% have a diminished appetite, with 
fluctuating appetite and gastrointestinal symptoms commonly experienced (Kalanatar-Zadeh et al. 
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2004; Lopes et al., 2007). This can be due to HD issues of low blood pressure, blood loss and 
anaemia. 
Medical conditions.  Co-morbidities, such as cardiovascular disease and diabetes are 
highly prevalent within the HD population, up to 70% in the study of Taiwanese patients by Tsai, 
Lu and Chang (2009).  This is in part due to the ageing HD population, an average of 66.9 years 
(RA, 2013).  Although inconclusive, some authors correlate these conditions with malnutrition 
(Carrero et al., 2013; Quershi et al.,1998).  Malnutrition risk may be heightened in the ageing HD 
patients if illness dictates hospitalisation; fasting for investigations, fatigue, anxiety and altered 
HD and also if there is increased dependence on social support (Carrero et al., 2013). 
Frailty and depression.  Locatelli et al. (2002) recognise that psychological distress, 
depression and poor quality of life are associated with HD.  Kalantar-Zadeh, Block, McAllister, 
Humphreys & Kopple (2004) report that there is an inverse correlation between quality of life 
scores and appetite, within their sample of 124 HD patients (p .001).  This sentiment that low 
mood can impair DI is reflected in clinical observation. 
Although written two decades ago Ikizler and Hakim (1996) aptly conclude a variety of 
authors work, terming malnutrition in the HD setting as a co-morbid condition in its own right.  
2.2 Rates of risk of malnutrition in the HD population 
Although much work has been done within the field of malnutrition, particularly with 
regards to incidence and prevalence, comparing studies is difficult due to the absence of a 
diagnostic framework (see Section 1.1).  Furthermore, there are limited nutritional studies with 
adequate methodological control, broad sample sizes and quality reporting in the HD environment 
(Elia, Zellipour, & Stratton, 2005).  This has led to inconsistencies in the reported rates of risk of 
malnutrition in HD, from 18% to 75% (Fouque et al., 2008).  An illustrative example is based on 
the frequently cited Dutch study by Visser et al. (1999), in which 36% of ESRF patients were 
malnourished (using SGA, see later).  This was however based on 13 patients receiving HD, 
within a sample of 2 different dialysis modes and research was 16 years ago.  With cultural, 
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historical and environmental changes over this period, results hold limited value and applicability 
to the UK HD population.  A seven year multicentre study in a larger Dutch population (n=1601) 
observed lower rates of risk of malnutrition (28%), however results were constrained by the lack 
of quality reporting on methodological control across the 38 centres involved and with baseline 
differences in ethnicity to the UK (with 92% of the sample white) (de Mutsert et al., 2009).   
In 2010 RA highlight the lack of sound research for numerically definining risk of 
malnutrition within the UK, by quoting rates obtained from a review written two decades ago 
(Ikizler & Hakim, 1996).  Current LTHT data is consistent with this however,  at 43%, identified 
by the dietitian within a small patient number (N=14, see piloting summary in Appendix 1).   
Although exact rates of malnutrition are not confirmed, the nutritional vulnerability of the 
HD population, 500 patients locally at LTHT and over 23,000 patients nationally (RA, 2013), 
cannot be disputed.      
2.3 Identifying an NST for the HD population 
Despite the overwhelming research placing NS as a high priority requirement in the HD 
setting (KDOQI, 2000; Locatelli et al., 2002; RA, 2010), failings exist in the development and 
testing of NSTs due to key determinants, in Table 2.1, often being overlooked (Elia et al., 2005).   
 
Table 2.1 
Established NST determinants, adapted from the BDA (1999, p.3) 
Tool 
requirement 
Rationale Comment 
Evidence 
based 
NST should incorporate defined 
nutritional principles 
Must be appropriate for the patient 
group and setting 
A powered 
study 
A powered study to avoid type 1 and 
type 2 statistical error 
Must be representative of the 
intended population 
Valid Sensitivity- able to correctly detect 
patients at risk (or those malnourished)  
Specificity- able to correctly detect 
patients who are not at risk  
The criterion measure must be the 
most superior measure available 
for identifying risk of malnutrition, 
to test against the NST 
Reliable NST should be tested by the intended 
users  
Differences between users may be 
relevant for future implementation 
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Practical Primarily it must be user-friendly and 
appropriate for the intended setting 
User and patient feedback must be 
collated to consider improvements  
 
Jones, J. (2002) in her comprehensive review of 44 papers, headlines the particular 
criticisms of NST testing in ESRF patients to be a lack of justification of NST derivation, use of 
unsubstantiated nutritional parameters as the criterion measure and insufficiency in study details.  
The criterion measure within a study sets the benchmark for its quality, providing study 
outcomes based on comparison with the test variables (Elia & Stratton, 2011).  Deviation from the 
most superior measure available, with unsubstantiated criteria, questions the validity of the study 
(Jones, J., 2004c).  Cooper et al. (2002) for example, used total body nitrogen as the criterion 
measure, of which Desbrow et al. (2005) questioned the reliability within overweight patients.  
The conclusion by Cooper et al. (2002) that a diagnostic tool (SGA) holds low sensitivity with 
malnutrition is therefore of limited value.  Similarly, Yamada et al. (2008) use a diagnostic tool 
based on albumin levels as the criterion measure and with study results they discredit 5 NSTs, 
which is inappropriate when it is widely accepted that albumin is an insensitive marker of 
nutritional status (Locatelli et al., 2002; KDOQI, 2000; Quershi et al., 1998).  Furthermore, they 
excluded malnourished patients and therefore the sample was not representative. 
Dietetic clinical judgement (DCJ) based on expert dietetic assessment (Table 2.2) is the 
acknowledged criterion measure in NST validation, with the absence of consensus diagnostic 
measures (Bennett, Breugelmans, Meade & Parkhurst, 2005; Van Bokhorst et al., 2013).   
 
Table 2.2  
Features of dietetic assessment, adapted from the BDA (1999) and Gower (2002) 
 Dietetic assessment 
1. Diet history taking to assess DI 
2. Nutritional requirements based on therapeutic guidelines and evidence 
based practice 
3. Weight history (as percentage weight loss and BMI) 
4. Anthropometry to examine physical measurements of body composition 
5. Subjective Global Assessment (SGA), a scoring technique to evaluate key 
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nutritional risk variables and physical appearance measures 
6. Social factors 
7. Medical information (including previous medical history, concurrent 
illness, medications and treatment) 
By ignoring the underpinning NST principles (Table 2.1) introduction of an unvalidated 
NST may not only inappropriately worry the patient that they are at risk of malnutrition, but also 
waste resources by incorrectly referring patients for dietetic intervention (described by The BDA, 
1999; Ferguson, , Capra, Bauer, & Banks, 1999).  Oakley and Hill (2000) reported a projected 
77% increase in referrals as a result of future implementation of their ill-tested NST, with bias 
introduced by the researcher and scoring altered retrospectively.  This estimated increase is a 
significant demand on dietetic resources and therefore the results highlight that an NST needs to 
be sensitive (correctly identifying those at risk) and specific (correctly identifying those not at 
risk), otherwise resources may be unduly exhausted. 
  Regardless of the flaws within the current evidence base of NST development and testing, 
lessons can be learned (Jones, J., 2004a).  The following critique of two frequently studied tools 
has informed previous LST piloting and the current study (Appendix 1).   
2.4 Tool 1  Malnutrition Universal Screening Tool (MUST)  
MUST (in Appendix 3a) is advocated by the NHS as the generic NST of choice for 
patients admitted to hospital.  MUST is based on a sound theoretical framework, having content 
validity, with robust objective measures and created by a panel of multi-disciplinary experts 
(BAPEN, 2003).  It has tested favourably by multiple authors on multiple occasions, in mixed 
hospital patient groups, of differing demographics and with varied co-morbidities (Kondrup, et al., 
2003; Van Bokhorst et al., 2013).  Correspondingly, 82% of hospitals surveyed in the UK have 
adopted this validated NST (reported by 205 hospitals, BAPEN, 2014).  Unfortunately, this well 
designed and tested NST is not valid in the HD population, with many studies simply omitting 
representation of this patient group (as seen Elia et al., 2005).  
2.4.1 Testing MUST in ESRF.  Bourke, Mafrici, Livesey, Peacock and Roe (2010) 
demonstrated MUST insensitivity in ESRF patients, reporting that DCJ identified more than twice 
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as many hospital patients to be at risk of malnutrition than MUST (43 compared with 18).  
Similarly, Lawson, C., Campbell, Dimakopoulos and Dockerell (2012) found in their study of 190 
patients, MUST only had 53.8% sensitivity and 78.3% specificity to the criterion measure, 
provided by a dietitian,.  Comparably, many NHS diagnostic tests have a sensitivity and 
specificity level of 70% (to be discussed in Section 5.4.1), therefore showing MUST’s impaired 
performance in identifying those ESRF patients at risk.  The results may have been skewed in 
Lawson, C. et al. (2012), as there was missing data in 54/276 patients.   
In the HD setting, the suboptimal performance of MUST is transferred, shown by Fisher et 
al. (2011) with MUST having a sensitivity of 31% and specificity of 95% in a sample of 65 
handpicked HD patients thought to be at risk of malnutrition, identified by a N/S.  Equally, Hyam, 
Jackson, Hart and Engel (2010) reported that MUST failed to identify 32 HD patients as 
malnourished, as compared with SGA (p= .05).   
The main reason for the observed insensitivity of MUST  in HD patients is due to its 
inflexibility in patients with altered fluid balance.  Fluid status in ESRF can range from severe 
fluid overload to dehydration as a result of reduced (or completely absent) urine output and due to 
fluid removal on HD (one to four kilograms, three times a week).  Without appropriately adjusting 
a patient’s weight for fluid weight, BMI and percentage weight loss calculations can lead to 
inaccurate conclusions about nutritional status.  BMI and percentage weight loss appear as two 
thirds of the contents of MUST and therefore MUST is significantly undermined in the HD 
setting.  This limitation is acknowledged by its authors and consequentially, RA conclude that due 
to this potential fluid bias objective measures using body weight (BMI and percentage weight 
loss) require an ‘extra level of interpretation’ (RA, 2010, p.10).   
2.4.2 The content of MUST.  Despite the concerns of using weight calculations in this 
setting, BMI and percentage weight loss, research suggests that they remain as core nutritional risk 
variables for inclusion in an effective HD NST.  Campbell, Bauer, Ikehro and Johnson (2013) 
reported BMI as a predictor of poor outcome (p .001) and although this is an anticipated result, the 
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study lacked the acknowledgment of whether flesh weight had been appropriately adjusted for and 
therefore the conclusions may have been diluted.  Similarly, Campbell and Maclaughlin (2010), 
reported that percentage weight loss correlated with mortality risk (by three-fold, p= .02), even 
after analysis adjustment for disease severity.  Campbell and Maclaughlin (2010) appropriately 
use the goal weight a patient is at the end of dialysis, ‘target weight,’ for their nutritional 
calculations (consistent with Quershi et al., 1998).  Target weight at the end of dialysis is the most 
appropriate weight to use, based on clinical practice, as this has been set by the renal multi-
disciplinary team as the weight at which the patient is not carrying excess fluid.  Inaccuracies can 
be introduced even with these objective measures having best guess adjustments, due to the 
complexities involved in estimation and therefore qualitative weight change also provides value 
(Ferguson et al., 1999; Unpublished data in Appendix 1). 
The third question from MUST incorporates acute illness and so in a population with 
chronic ESRF this is not principally relevant and may also contribute to the reduced accuracy 
seen. Janardhan et al., 2011 found that a question about medical condition and co-morbidities led 
to reduced NST accuracy due to the reliance on patients’ memory and this was consistent with 
previous LTHT pilot work (Appendix 1).   
2.4.3 Other relevant MUST considerations.  MUST is praised for its practical 
acceptability, as observed by Stratton, Cawood, Rust, Walters, & Elia (2010) scoring highly on  
ease and quickness of use (96% and 98%, respectively) with 205 patients attending a clinic 
appointment, of which the mean age (55 years) was comparable to those on HD.  This format is 
thought not only to reduce the time burden for staff of overcomplicated and unnecessary 
questions, but in turn improve compliance (BAPEN, 2003).   
2.5 Tool 2 Subjective Global Assessment 
The SGA tool (Appendix 3b) and its contents have been acknowledged by high level 
national and international committees, such as KDOQI (2000) and RA (2010) to be of value in the 
HD setting.  SGA is however an assessment tool, comprehensive and detailed and can form as part 
0300006 
 
25 
 
of DCJ, alongside other nutritional parameters, in Table 2.2 (Steiber et al., 2004).  By its very 
definition then, SGA contradicts the ethos of an NST; quick, simple and for those without 
nutritional qualification, illustrated in Figure 1.2.  
Despite its definition, there are questions over the transferability of SGA to the current HD 
population for the purpose of assessing risk of malnutrition (KDOQI, 2000; Van Bokhorst et al., 
2013).  These concerns are based on the origins of SGA three decades ago, created by a group of 
clinicians for use in a surgical population and for the purpose of predicting clinical outcomes 
(Detsky et al., 1987).  Furthermore, there are currently eight various forms of SGA, which makes 
comparing studies difficult, particularly as tool modifications are described in Campbell, Ash, 
Bauer and Davies (2007) and Steiber et al. (2004) as unsubstantiated and inadequately tested.  
Kalantar-Zadeh, Kliener, Dunne, Lee & Luft (1999) for example, developed a seven tier scale of 
an older three scale model, to allow for an expansion in risk categories.  They inappropriately 
discounted the three scale SGA, as the seven tier compared better with an unrecognised criterion 
standard (anthropometric and biochemistry).  The study is further limited by its small sample size 
(N=40) and thus confirms that SGA should be used by an expert in combination with other 
measures (Jones, C., Wolfenden & Wells, 2004).   
2.5.1 Testing of SGA.  Despite the numerous versions, the subjective thread of SGA is 
advocated by KDOQI (2000) and RA (2010) as being of primary importance in the HD population 
due to the fluid shifts causing inaccuracies associated with objective data (weight loss and BMI)  
(Section 2.4.1).  Enia, Sicuso, Alati & Zocalli (1993) provide an illustrative example, reporting 
that the subjective evaluation of physical appearance (PA) correctly identified those at risk of 
malnutrition, whereas percentage weight loss failed to identify them, presumably as the authors 
failed to adjust flesh weight for fluid bias.  PA is found to be a particularly difficult element of 
subjective assessment in the ageing HD population, as with functional ability, as SGA demands 
the categorisation of solely nutrition-related decline and not age related alterations (Johansen et 
al., 2013).  This challenge is acknowledged by de Mutsert et al. (2009) who although provided 
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workshops for researchers, decided to alter questions relating to PA due to concerns over its 
inaccuracy.  LST piloting (Appendix 1), although based on only 28 patients, showed that PA, 
unlike functional capacity, is of benefit (and is recommended by RA, 2010).  Bryan, Jones & 
Russell (1998) explain that despite the variability in subjective evaluation of PA, accuracy is 
improved with staff that are in frequent contact with their patients, as is the case in HD. 
Subjectivity, by its very nature puts SGA at a disadvantage in terms of its precision and so 
it is imperative to test the NST in conditions that mimic the perspective of the future user, their 
nutritional knowledge and their relationship with the patient before NST implementation 
(Locatelli et al., 2002).  Campbell et al. (2007) describe that of 14 studies involving SGA, only 
one study had an N/S as the administrator and instead dietitians or physicians were commonly 
seen, as is the case in Campbell et al. (2013), thus garnering results that are not fully applicable.  
Fisher et al. (2011) considered patient self-completion, which is important in the current NHS 
climate of shared care, whereby patients are being empowered to be active in their own health.  
They reported good sensitivity, however over 50% (of 65 patients) required assistance, thus 
defeating the purpose of self-completion.  The figure of patients unable to self-complete is higher 
than expected and may be a result of an older sample, although age was unfortunately not stated.   
Testing SGA measurements between intended user groups (CSW, N/S and patient) is also 
rarely seen, with Steenson, Vivanti, and Isenring (2013) reporting only 13% (15/249) of published 
studies evaluated reliability.  Visser et al., (1999) do assess reliability of SGA measurements 
between four N/S, however this was in a limited sample of 22 patients and a detailed methodology 
was lacking, thus further research is required.  
2.5.2 The content of SGA.  Despite the study limitations discussed above, SGA has been 
tested within the HD setting and the nutritional risk variables SGA contains may provide value in 
identifying malnutrition risk.  SGA (in Appendix 3b) incorporates all three evidenced core 
nutritional criteria that are essential for an NST; BMI, percentage weight loss and DI (Fouque et 
al, 2008; NICE, 2006).  The former 2 have been discussed in Section 2.4.2 and PA, functional 
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capacity and co-morbidities have been outlined in preceding sections.  The remainder core 
nutritional risk variable DI, alongside the closely linked SGA variables, appetite and 
gastrointestinal symptoms will be discussed here. 
Although DI and appetite are often used interchangeably, through the literature and in 
clinical practice, Kalantar-Zadeh et al. (2004) describe that there are important differences, as the 
actual amount eaten and the desire to eat, respectively.  This distinction is fundamental in the HD 
setting, where fluctuating HD related symptoms and gastrointestinal symptoms commonly lead to 
a diminished and variable appetite (in 43%, Burrowes et al, 2005).  These transient changes in 
appetite do not however necessarily affect DI and the longer term marker of nutritional status, 
(KDOQI, 2000; Unpublished work in Appendix 1).  NICE (2006) describe that the longevity over 
which a reduced appetite and gastrointestinal symptoms affect unintentional reductions in DI is 
the primary factor for consideration.  A reduced intake for 5 days or more has been suggested by 
BAPEN (2003, p.28) as the timeframe at which risk of malnutrition begins.  Nonetheless, both 
reduced appetite and DI have been associated with poor outcomes, as correlated by Burrowes et 
al. (2005), leading to increased hospitalisation (28%) and mortality (53%).  Even though these 
results were not statistically significant on adjustment for co-morbidities, they suggest that DI and 
appetite are important variables for NST inclusion.  
2.5.3 Other SGA considerations.  There is limited reference to the inclusion of the 
minority HD patient group that are unable to converse with staff, due to dementia, learning 
difficulties or language barrier.  This patient group accounted for 6% of 275 general inpatients, 
with a mean age of 55 years, in the work by Cawood, Elia, Sharp and Stratton (2012).  Ferguson et 
al. (1999) simply exclude this patient group and automatically refer them to the dietitian, 
regardless of their nutritional status, which ultimately may increase inappropriate referrals.  Bryan 
et al. (1998) recommend carer involvement with NST completion where possible, although 
accuracy has not been tested here.   
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Detsky et al. (1987) and de Mutsert et al. (2009) recognise that SGA has a unique way of 
coping with unanswered questions, by using an averaging system for questions that are answered.  
Although effectiveness of partially completed SGA tools has not been comprehensively tested in 
this patient group averaging NST results may allow effective NS in this sensitive HD population.   
2.6 Summary 
This chapter has sought to map out the key issues associated with the development and 
testing of an NST in the challenging HD population.  It is hoped that the importance of identifying 
those at risk of malnutrition is portrayed, alongside the realisation that if ignored risk of 
malnutrition will lead to overt malnutrition and associated clinical and financial repercussions.  
Although there is no common agreement over the definition and diagnosis for those at risk of 
malnutrition and there are a limited number of quality studies, the UK expert Renal Association 
strive to highlight the complexity of their concern.  Despite MUST being over 10 years old, there 
remains no replacement for it, however due to its inflexibility with fluid balance it performs 
poorly in this population.  SGA has a higher international profile, however despite adaptations it is 
not efficient enough as an NST, although the nutritional risk variables it contains and its scoring 
system may be of value.  There is firm evidence to support the justification of developing and 
testing a new instrument for the HD setting, before considering implementation.  Table 2.3 draws 
together the essential parameters identified from this critical appraisal, from clinical observation 
and previous pilot studies (Appendix 1, 2), which are required to move LST towards validation. 
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Table 2.3 
NST validation requirements 
LST Comment 
Tool aim Highlight those at risk of malnutrition (including those that are malnourished)  
Risk variables 
 
Include a mix of objective and subjective questions. Include the 3 core 
nutritional criteria; weight as BMI, percentage weight loss and DI. Plus 
appetite and PA.  Exclude gastrointestinal symptoms, functional capacity, 
dialysis years, co-morbidities & biochemistry 
Tool outcome Link to a nutritional care plan 
Criterion measure DCJ  
Education Provide guidance for administrators, to consider the complexities in HD 
Practicalities Test for its practical acceptability, in the future environment and with intended 
users (patients, CSW and N/S)  
Testing and 
analysis 
Test within a powered study and representative sample and use appropriate 
analysis techniques (Jones, J., 2004a).   
 
2.7 Research objectives 
1.  To test the sensitivity and specificity of the LST in identifying malnutrition risk in HD 
patients, from a computer generated sample of convience.  LST is completed by a CSW 
and is compared to the criterion measure of DCJ. 
2.  To evaluate the appropriateness of LST risk variables by assessing accuracy of 
incomplete tools and analysing each risk variable. 
3.  To assess the reliability of the LST within a subset of patients by the intended users; 
CSW, the N/S and the patient. 
4.  To collate questionnaire feedback completed by the intended users to inform the 
appropriateness of using the LST. 
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Primary hypothesis. 
H1  is that the LST will have a high level of sensitivity compared with DCJ in 
identifying HD patients at risk of malnutrition.  
H 0  is that the LST screening tool will not have a high level of sensitivity compared 
with DCJ in identifying HD patients at risk of malnutrition.  
Secondary hypotheses  
H2   The LST will have a high level of specificity compared with DCJ in identifying HD 
patients at risk of malnutrition. 
H0   The LST will not have a high level of specificity compared with DCJ in identifying 
HD patients at risk of malnutrition. 
H3  The LST will not be equally effective when the risk variables are not fully 
completed. 
H 0   The LST will be equally effective when the risk variables are not fully completed.  
H4  The reliability of the LST will be equally as accurate when the tool is utilised by 
different users. 
H0   The reliability of the LST will not be equally as accurate when the tool is utilised by 
different users. 
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Methodology 
3.1 Study design 
This study was a clinical audit comparing the effectiveness of LST in identifying risk of 
malnutrition, with the criterion measure of DCJ, in an HD patient group. 
3.1.1 Dependent and Independent variables.  The dependent variable was the criterion 
measure of DCJ, a non-validated standard to identify malnutrition risk.  This is in keeping with the 
work by Desbrow et al. (2005), who considered SGA as the dependent variable.  DCJ was based 
on specialist skills obtained through registered dietetic training, evidence based practice and 
clinical experience of one renal specialist dietitian (‘the researching dietitian’), the author.  DCJ 
encompassed the evaluation (Appendix 4) of current patient multi-disciplinary records, dietetic 
records and the LTHT computer system and assessed;   
 Objective weight data; flesh weight, body composition, BMI and weight loss   
 Recent assessment; nutritional requirements, DI, anthropometry and SGA 
 Medical information; biochemistry, dialysis details and medical history 
 Social information; mood, confusion and neglect 
Fifty two patients required direct contact by the dietitian due to insufficient detail (or if the last 
assessment was over two months ago).  Oakley and Hill (2000) and Weekes, Elia & Emery (2004) 
have a similar approach for DCJ scoring and provided guidance for this study.  On balancing these 
risk variables the dietitian allocated a score on the same malnutrition risk category continuum as 
the independent variable (as encouraged by Jones, J. 2004a), to be discussed in Section 3.1.2.  
The independent variable was the LST ( in Appendix 2), tested in paper format which 
incorporated six risk variable questions, of which four were subjective and two were objective. 
Each question had a numerical score attached to signify malnutrition risk.  LST was completed by 
one HD based CSW, one HD based nurse and 13 patients.  The overall risk score was generated as 
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a mean from the questions answered and in turn corresponded to a risk category (discussed in 
3.1.2). 
3.1.2 Outcome measures.  Table 3.1 illustrates how the DCJ and LST numerical scoring 
system converted to a malnutrition risk category.  For LST, the numerical score was a mean result 
and so if this figure fell between two risk categories, the traditional cut-off of greater than 0.5 was 
used to round up the score to the next risk category (as illustrated in the second row of  Table 3.1). 
 
Table 3.1 
Risk category continuum 
Score category 1 2 3 4 
Including ranges 1-1.4 1.5-2.4 2.5-3.4 3.5-4 
Risk category No Low Mild and moderate Severe 
 
Categorisation along a continuum such as this is derived from theoretical frameworks 
associated with MUST and SGA, as detailed by BAPEN (2003) and Steiber et al. (2004)and has 
been tested through previous LST piloting (Appendix 1).  For the purposes of the audit a score of 
3 plus indicated 'at risk' of malnutrition and stipulated a dietetic referral, established by the LTHT 
renal dietetic team.  A score category below 3 indicated limited clinical risk (‘low risk’) and 'no 
risk' and indicates no referral is required, just future monitoring.  
3.2 The population and subjects 
3.2.1 Ethical approval.  This study did not require NHS ethical approval (see Appendix 
5), as it falls under the NHS definition of service development (NICE, 2002).  It has received 
ethical approval from the University of Chester (see Appendix 5).  There was a great emphasis 
placed on following the Health and Care Professions Council standards of conduct (2013).  There 
was also peer approval within the wider renal team (see Appendix 5), with peer checking at 
regular intervals to monitor compliance with the Caldicott Principles (as summarised by NICE, 
2002). 
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Each subject consented using the patient information sheets and written consent forms (see 
Appendix 6).  In 4 patients who were unable to converse or consent, a carer who attended the 
dialysis unit with the patient, translated and consented to take part on their behalf.  In 9 patients, 
where there were no carers available, the LST was completed in the patients’ best interest (with 
renal consultant permission).  The subjects did not receive reimbursement for their participation.   
3.2.2 Sample size calculations.  The sample size was estimated as N=139 using 
calculations by Jones, J. (2004a) based on the statistical analysis required for NST testing (see 
Appendix 7 for further justification).  Other relevant researchers have cited this author (Campbell 
et al.,2007) and support this analytical technique (Tsai et al., 2009).  CSW and dietetic research 
time was agreed by the renal and dietetic team in order to facilitate reaching the desired sample. 
Reliability testing was completed by two groups; an N/S and a patient sample, as both are 
intended future users (Section 2.5.1).  N/S involvement was set at a clinically feasible amount, at 
10% of the sample (14 patients), as funding was not granted and so involvement formed as part of 
clinical duties.  A figure of 10% (n=14, 1 declined) was decided for patient self-completion, based 
on a balance between feasibility, envisaged patient burden and the small number of patients who 
are able to self complete (at 12% from pilot studies, Appendix 1).  These figures were also guided 
by Ferguson et al. (1999) and Lawson, C. et al. (2012) who carried out NST reliability testing in 
8% of their sample (in 32/408 and 23/276 respectively). 
3.2.3 Study sampling.  LST efficacy was tested in the target population, Table 3.2. 
Table 3.2 
Study sample criteria    
Inclusion criteria Rationale 
All adult patients with a 
diagnosis of ESRF 
undergoing  HD for more 
than 3 months 
The 3 month cut-off  is consistent with the study by Campbell et al. 
(2013) and de Mutsert et al. (2009), allowing for an appropriate 
period of adjustment.  HD patients are standardly assessed by the 
dietitian on starting dialysis, without the need for NS. 
Daytime HD patients  Logistical reasons. 
Satellite and main site  Representative sample of stable and less stable HD patients. 
0300006 
 
34 
 
Exclusion criteria Rationale 
HD patients in hospital These patients are in a different clinical environment  
Patients receiving other 
modes of dialysis therapy 
This is a separate population segment, with a different treatment 
mode and thus not the intended population 
3.2.4 The sample population defined.  The LTHT renal computer system generated a 
report that identified eligible patients from a sample of convenience (N=156).  The report 
randomly ordered the patients into shifts, for ease of use and then allocated each patient a number. 
16 patients failed to complete and this was due to hospital admission (n=3), death (n=7), 
transplant (n=3) and declining to take part (n=3).  The attrition rate of 1% is similar to NST testing 
seen in the pilot study (Appendix 1) and in the 2012 work by Bennett et al.  At the end of data 
collection, numbers recruited totalled 140, meeting sample size requirements.  With a low number 
of patients failing to complete, the study sample (see Table 3.3) was thought to be representative.  
 
Table 3.3 
Sample characteristics (N=140)  
Characteristics Results 
Dialysis  Morning HD=53% (74/140), Afternoon HD=47% (66/140) 
Three times a week dialysis=96% (remainder were twice a week) 
Mean time on dialysis=4.2 years (± 5.2) 
Demographics Mean age=62.2 years (±  16.1, range 19-89)   
Male=64% (82/140), female=39% (38/140) 
White=74%, Asian=14%, Black=12% 
Medical More than one co-morbidity=66% 
Diabetes=17% 
Smoker=20% 
Nutritional Target weight=65.7 Kg (19.3kg-89.6 Kg) 
BM=27.7 Kg/m2 (± 6.7 Kg/m2) 
Percentage weight loss=1.4 % (± 3.4%) over 3 months.   
 
3.3 Procedures 
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3.3.1  A: Standardised protocol.  At the outset of the study, the researching dietitian 
provided one separate education session for the CSW and the N/S (Appendix 8), in keeping with 
de Mutsert et al. (2009) and Weekes et al. (2004).  The aim of the session was to provide guidance 
on ethical considerations and to aid consistency in methodological approach as outlined in Table 
3.4 (and Appendix 8).  
 
Table 3.4 
Standardised protocol for the CSW and N/S  
Step  
1 
Completion 
order 
On gaining consent (Appendix 6), the subjective questions (A to D) 
were asked first, to reduce user bias of knowing the objective measures.  
Step 
2 
Objective 
data 
Obtaining electronic objective weight and height data was in keeping 
with Gower, (2002) (Appendix 8, handout 2).   
Step
3 
Choosing 
an 
appropriate 
risk score 
The user’s clinical judgement and their interpretation of patient 
responses were required for choosing the appropriate risk level (of 
which a standard technique was encouraged, in Appendix 8).  If unclear 
of the appropriate answer, questions were left unanswered. 
 
3.3.2  Audit data collection.  The data collection period was over 11 weeks, from May to 
August 2014.  Figure 3.1 provides an overview of the audit, detailing the order and timings of both 
arms of the study, including the interaction between parties and what happened to the patient at 
each step.   
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Figure 3.1. An overview of the study procedure 
 
As outlined in Figure 3.1, with the computer report of eligible patients, the CSW co-
ordinated communication with all researchers involved and researchers were kept blind to others 
results (as advocated by Jones, J. 2004c).  The short timeframe of 7 days between methods aided 
fair testing conditions, by reducing the chance of alterations in malnutrition risk in a population 
where nutritional status is not a static entity (Weekes et al., 2004).  Further methodological detail 
and justification is provided within Appendix 8. 
A non-validated semi-structured questionnaire (in Appendix 9) was completed for NST 
feedback by each intended user group (recommended as part of the audit cycle by Jones, J., 2002).     
The independent dietitian collated results and two weekly for ethical reasons, checked if 
any patients had been highlighted as at risk (a score of greater than 3), based on DCJ, to trigger a 
dietetic referral.  Data was not compared by the researching dietitian until all data had been 
collected. 
 
Step 1a.   
13 patients (identified 
by the nurse as able) 
self-completed LST 
and a questionnaire, 
over 14 days 
Step 1b.   
The CSW screened 
these patients in 7 days 
Step 2.  
Using LST, 127 patients screened by 
the CSW, over 45 days. 16 patients 
were randomly chosen to complete a 
questionnaire.  CSW completed a 
weekly questionnaire 
Step 3.  
14 patients were randomly 
chosen by the CSW for the 
nurse to test LST, within7 
days.  The nurse completed 
a questionnaire 
Step 4. 
The researching dietitian created the criterion measure 
for N=140 within 7 days of CSW screening 
Computer generated report (N=156) based on two 
dialysis units at LTHT
140 patients were consented on dialysis by the CSW with a 
patient information sheet and consent form (appendix 6). 
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3.4 Data management 
All data has been analysed using the Statistical Package for Social Sciences software 
(SPSS UK Ltd 2012, version 21).  All of the data was checked for errors, missing data and 
outliers.  During analysis the outliers were found to be patients at severe risk of malnutrition, due 
to their reduced frequency (n=7).  These patients need to be considered in the data, so that the 
NST maintains sensitivity across a range of patient characteristics.   
   Continuous variables including characteristics such as age, time on dialysis, weight loss, 
weight and BMI are presented as means and as standard deviations (Burrowes et al., 2005; de 
Mutsert et al., 2009).  None of the continuous characteristics were found to be normally 
distributed.  Log transformations were unlikely to be of benefit due to the small sample size 
(Field, 2013).  Non-parametric testing was therefore indicated for these characteristics, which is 
consistent with similar work by Campbell and Maclaughlin (2010) and Lawson, C. et al. (2012).   
The majority of the variables were categorical, as ordinal data; the LST and DCJ outcome 
measures or as nominal data; dialysis shifts, gender, ethnicity, smoking and co-morbid conditions 
(consistent with Cooper et al., 2002).  Categorical variables are presented as frequencies, 
proportions and tested with non-parametric statistics (Burrowes et al., 2005; Pallant, 2013).  
3.4.1  Statistical analysis.  All data was investigated by use of inferential statistics and 
statistical significance level was set at p< .05.  Table 3.5 outlines the aims of analysis, attached to 
the hypotheses and associated statistical testing, to be performed in Section 4. 
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Table 3.5 
Overview of statistical testing  
Section Analysis aims Rationale Main statistical testing 
4.1 Sample characteristics compared 
to national results. 
Assess LST 
transferability 
Non-parametric data using 
Mann-Whitney (U) to test for 
differences (N=140) 
4.2 Characteristics of those at risk 
and not at risk of malnutrition. 
Analyse group 
differences 
As above  
4.3 Analyse the sensitivity of the 
LST compared with DCJ  
Primary study 
aim (H1) 
Cross-tabulation with kappa 
(k) to test agreement with 
DCJ 
4.3 Analyse the specificity of the 
LST compared with DCJ  
Hypotheses (H2) As above  
4.4 Analyse effectiveness of 
incomplete LSTs 
Hypotheses (H3) As above, for LSTs that were 
not fully complete (n=13) 
4.4 Analyse the relationship of the 
LST risk variables individually 
and in combination with DCJ  
Hypotheses (H3) Non-parametric Spearmans 
Rho correlation (r) and 
multiple regression (β)  
4.5 Analyse the reliability of the 
LST amongst different future 
users 
Hypotheses (H4) Cross-tabulation and Kappa 
(k) to test agreement 
 
3.4.2  Reporting of results.  The data was formed as two groups in the main stem of the 
analysis by collapsing the four point scale, illustrated in Table 3.6, which is in keeping with the 
literature (Bennett et al., 2005; Campbell et al., 2013). 
 
Table 3.6 
Outcome measures as two groups 
Score category 1 to 2 3 to 4 
Risk category No to  Low Mild and Moderate to Severe 
Dietetic referral Not indicated Indicated 
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The ability of LST to identify two groups, firstly, those at risk and requiring dietetic 
referral and secondly, those not at risk that do not require a dietetic referral, is the primary 
outcome of this study and is paramount for future implementation.  Analysis of LST accuracy over 
four levels is also important in indicating the effectiveness of LST across the differing risk 
categories.   
3.4.3  Interpreting statistical testing.  The Shrout Classification, Table 3.7 (cited by 
Jones, J, 2004b, p.308), was used to interpret cross tabulation results (Table 3.5). 
 
Table 3.7  
Shrout Classification 
Kvalue Agreement 
0-0.10 Virtually none 
0.11-0.40 Slight 
0.41-0.60 Fair 
0.61-0.80 Moderate 
0.81-1 Substantial 
 
For interpreting the Spearmans Rho correlation analysis (Table 3.5) Cohen’s 1988 criteria 
was used, as detailed in Table 3.8 (cited by Pallant, 2013, p.139). 
 
Table 3.8 
Interpretation of the correlation coefficients 
r value Correlation 
0.1-0.29 Small 
0.3-0.49 Medium 
0.5-1 Large 
 
3.5 Qualitative data 
The nature of this study required a quantitative research model, with objectivity, although 
a qualitative approach was not discounted.  Consideration was given to patient interviews, 
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however due to the sample size and patient life-stage, semi-structured questionnaires for LST 
feedback were more appropriate (Figure 3.1).  Feedback was collated from 26/34 patients to 
explore discrepancies in numerical data and underlying themes, to enrich LST improvements 
(drawing on Jones, J, 2004a).   Literature appraisal fails to show substantive research in this area 
of NST development, with only one author using questionnaires alongside quantitative data 
collection (Weekes et al. 2004).  
Results 
4.1 The sample population 
140 patients completed the study, with 16/156 patients failing to take part (Section 3.2.4).  
The study sample characteristics are displayed in Table 3.3 and are compared with 2013 UK 
survey data (based on 71 UK centres, RA, 2013) in Table 4.1.  
 
Table 4.1 
Sample characteristics (N=140) compared with national HD data 
Sample characteristics Study population National data  
(RA, 2013) 
Age (Years), Median (range)  65.7 (19.3-89.6) 66.4 (not available) 
Over 65 years 53% 49% 
Over 75 years 26% 15.7% 
Gender (Male) 62% 62% 
Ethnicity White 74% 79.3% 
Diabetes (%) 17% (19% missing) 35% 
> 1 co-morbidity* (%)  65% (16% missing) 52.9% 
Cardiovascular disease (%) 4% (17% missing) 19% 
Smoker (%) 20% (30% missing) 14% 
Weight (Kg) (SD) 78.6 (± 20.9) Not collated 
BMI (kg/m2) (SD) 27.7(± 6.7) Not collated 
Weight loss (%) (SD) 1.4 (± 3.39) Not collated 
Note. *including emphysema, diabetes, malignancy and liver disease 
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National data is not available as raw data and so trends only are considered here, as 
opposed to statistical testing.   
4.2 Sample characteristics as two dichotomous groups 
The population can be defined as two subsets, in Table 4.2, as at risk of malnutrition (and 
requiring a dietetic referral) and not at risk of malnutrition (not requiring a referral), based on 
DCJ.   
 
Table 4.2  
Sample characteristics as two dichotomous groups 
Characteristics At risk(n= 15) 
 
Not at risk(n= 
115) 
 
Age (years), Mean (SD) 61.92 (±  
18.253) 
62.4 (± -15.7) 
Gender -Male (%) 52 64 
Ethnicity – White (%) 72 75 
Dialysis vintage, 
Mean(years),  (SD) 
 
5.09 (±  6.07) 
 
3.96 (±  4.96) 
Cardiovascular disease (%) 52 38 
Smoker (%) 24 17 
Diabetes (%) 5 62 
>1 co-morbidity (%) 77 62 
Post weight (Kg),  
Mean (SD) 
66.3  
(±  14.11)* 
81.27  
(±  21.27) 
BMI (Kg/m2), Mean (SD) 23.3 (± 23.3)* 28.6 (± 6.7) 
Weight loss (%),Mean (SD) 7.2 (± 4.2)* 0.8 (± 1.7) 
Note. * p<.001 
 
The only statistical difference identified between the groups was in weight, BMI and 
weight loss, which is an anticipated result (p< .0001).  Equally, these characteristics were the only 
ones that correlated with risk of malnutrition (r=.3 to.7) (p<.001) (shown in Appendix 10). 
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4.3 Sensitivity (H1) and specificity (H2) of the LST compared with DCJ  
 
4.3.1 Results as two dichotomous groups.  Figure 4.1 shows the patient numbers 
identified to be at risk of malnutrition (requiring a referral) and not at risk (not requiring a referral) 
(N=140), for LST compared with DCJ.   
 
 
Figure 4.1. Identified malnutrition risk (N=140) 
LST correctly identified 72% of patients to be at risk of malnutrition (sensitivity), as 
compared with DCJ.  LST correctly identified 100% of patients not at risk of malnutrition 
(specificity).  Statistically, there was substantial consistency between the results for DCJ and LST, 
as displayed in Figure 4.1 (k=.8) (p= .0001) (Pallant, 2013).  Furthermore, the discrepancy 
between LST and DCJ was not deemed to be statistically significant, χ2 (1, N=140)=2.38, p= .12.  
Sensitivity and specificity was considered further in two patient subsets, as outlined in 
Table 4.3, to assess if methodological differences altered results. 
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Table 4.3  
Sensitivity and specificity in patient subsets   
Subset analysis Sample 
number 
Sensitivity 
(%) 
Specificity 
  (%) 
Kappa 
Patients with fully completed tools 127 73 100 K=.8 (p< .001) 
Patients where DCJ based on direct 
contact (as opposed to records) 
88 75 100 k=.8 (p< .001) 
  
Accuracy of LST can be further analysed by the following calculations in Table 4.4. 
 
Table 4.4  
Further considerations for accuracy  
Accuracy calculations Results 
Mis-classification rate 4% 
Rate of accuracy 96% 
The likelihood ratio (the likelihood that the patient 
will test positive for the disease)  
7.4 
 
4.3.2 Referral rates.  Based on DCJ (Figure 4.1), 25/140 patients required dietetic 
referral, this equates to an 18% referral rate.  Table 4.5 illustrates estimated quarterly referral rates 
indicated by DCJ, current practice (43% of DCJ) and LST (72% of DCJ) at a local and national 
level.   
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Table 4.5  
Referral rates 
Method for screening Quarterly Quarterly 
difference to 
DCJ 
Annually Annual 
difference to 
DCJ 
DCJ identified  90 N/A 360 N/A 
LTHT with LST  65 25 260 100 
LTHT population currently  39 51 156 204 
National referrals*  for DCJ  
(using an 18% referral rate) 
4208 N/A 16, 832 N/A 
National referral numbers for 
LST (72% of DCJ) 
3029 1179 12,119 4713 
National referral numbers for  
current rates (43% of DCJ) 
1809 2309 7237 9595 
Note. * based on Renal Registry numbers of 23,378 (RA, 2013). 
 
4.3.3 Audit results expanded over a scale of four.  Effectiveness of LST in identifying 
malnutrition risk across four risk categories is illustrated in Figure 4.2. 
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Figure 4.2 Malnutrition risk along a scale of four 
There was a high association between the results for LST and DCJ across a scale of four, 
χ2 (9, N=140)=120.89, p< .001.  Furthermore, there was no statistical discrepancy between the 
results for both methods, χ2 (3, N=140)=6.1, p= .11.  On the other hand, Kappa analysis showed 
that there was only fair agreement (k=.48) (see Table 3.7).  Table 4.6 and Figure 4.3, illustrates 
that this result suggesting limited consistency between DCJ and the LST may be attributed to the 
discrepancies between the no risk and severe risk groups.  
 
Table 4.6  
Accuracy of LST compared with DCJ across a four point scale LST (N=140) 
Variable Score 1 
= No risk 
Score 2 
= Low risk 
Score 3= Mild- 
moderate 
Score 4 
= Severe 
Accuracy 89% 98% 94% 17% 
 
LST
no risk
low risk
mild and moderate
severe
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Figure 4.3. Agreement between malnutrition risk categories for DCJ and LST 
 
There were 37 discrepancies across the results for the four point scale between DCJ and 
LST, seen in Figure 4.4 and all discrepancies were by 1 category only.   
          
 
Figure 4.4. Causes of discrepancy  
 
Despite these discrepancies, results can suggest rates of risk of malnutrition (Table 4.7). 
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Table 4.7  
Incidence of malnutrition risk 
Risk of malnutrition Based on DCJ (%) Based on LST (%) 
Score greater than 3; 
Category 3+4= 
 
13%+7%= 20% 
 
12%+1%=13% 
Score greater than 2; 
Category 2+3+4= 
 
29%+13%+7%=49% 
 
29%+12%+1%=42% 
 
4.4 Risk variables in LST completion (H3) 
4.4.1 Analysis of partially completed tools.  The comparative efficacy of tools that were 
not fully complete (n=13) showed a sensitivity of 67% and specificity of 100%.  There was 
moderate agreement (k=.8) (Table 3.7), although this was not as significant as the LSTs that were 
fully completed (p= .005, see Table 4.3).   
4.4.2 LST risk variables - univariate analysis.  It is important to consider the usefulness 
of the LST objective and subjective nutritional risk variables (see Section 2.5.1).  Table 4.8 shows 
the correlation of LST nutritional risk variables, as individual variables, compared with 
malnutrition risk as assessed by DCJ (in fully completed LSTs, n=127). 
 
Table 4.8  
 
Spearmans rho correlation analysis of LST risk variables to DCJ (n=127) 
Risk variable A- Weight 
change 
B- DI C-
appetite 
D-PA E- BMI F-Weight 
loss 
Correlation co-
efficient 
.58* .46* .40* .68* .49* .75* 
Interpretation Large Medium Medium Large Medium Large 
Co-efficient of 
determination 
33% 21% 16% 46% 24% 56% 
Note. *p<.001 
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4.4.4 LST risk variables - multivariate analysis.  Table 4.9 shows regression analysis of 
LST nutritional risk variables, relative to each other, compared with malnutrition risk as assessed 
by DCJ (in fully completed LSTs, n=127).  
 
Table 4.9 
Contribution of LST risk variables    
RISK VARIABLE Standardised 
Beta value 
Unique 
contribution*
P value 
A-weight change .65 1 .335 
B-DI .20 4 < .001** 
C-appetite .04 6 .445 
D-PA .16 5 .155 
E-BMI .35 3 < .001** 
F-Percentage weight loss .46 2 < .001** 
Note. *1=highest ** statistically significant 
 
Stepwise analysis showed the strongest subset of nutritional risk variables in LST for 
identifying risk of malnutrition, to be weight loss (F), BMI (E), DI (B) and PA (D) (Appendix 10, 
model 4, at R=.903).  This model of risk variables explains 90% of the variance.  
A scatterplot provides an illustration of the appropriateness of risk variables.  Figure 4.5 
displays results for BMI (Variable E) across the sample, including the HD established cut-off 
point of risk of malnutrition at 23kg/m2 (Kovesdy & Kalantar-Zadeh, 2012).  A further objective 
scatterplot for weight loss can be seen in Appendix 10.  
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Figure 4.5. BMI of those at risk of malnutrition and not at risk of malnutrition 
 
Figure 4.6 shows subjective questioning results for the sample for appetite (variable C) (see 
Appendix 10 for further scatterplots). 
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Figure 4.6  Appetite of those at risk of malnutrition and not at risk of malnutrition 
4.4.5 Producing a subset.  Without appetite sensitivity is 73%, specificity is 100% and 
there was moderate agreement, n=127, k=.79, p= .0001. 
4.5 Analysis of the reliability of LST (H4)  
Reliability testing was based on the patient versus the CSW (see Table 4.10) and the N/S 
versus the CSW (Table 4.11).   
 
Table 4.10  
Reliability with the patient 
 Patient versus CSW CSW versus DCJ Patient versus DCJ 
Sensitivity 2/2 (100%) 1/2 (50%) 1/2 (50%) 
Specificity 11/11 (100%) 11/11 (100%) 11/11 (100%) 
Agreement Substantial (k=1) 
(p<.001) 
Moderate (k=.63) 
(p= .02) 
Moderate (k=.63) 
(p= .02) 
 
Table 4.11 
Reliability with the nurse 
 N/S versus CSW CSW versus DCJ N/S versus DCJ 
Sensitivity 2/2 (100%) 1/2 (50%) 1/2 (50%) 
Specificity 11/12 (92%) 12/12 (100%) 11/12 (92%) 
Agreement Moderate (k=.63) 
(p= .01) 
Moderate (k=.63) 
(p= .01) 
Fair (k=.42)  
(no significance p= .12) 
 
 
3% (4/140) patients had the LST completed by a carer and these were consistent with DCJ. 
4.7 Qualitative analysis 
26/34 questionnaires were completed, 9 patients declined and not all questions were 
answered (see Table 4.12). 
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Table 4.12  
LST feedback 
Questions Completion 
number 
Frequency Comments 
Was the rationale for the tool 
clear? 
26 Yes=26/26 
(100%) 
‘Easy to understand’ 
 
Were the questions clear? 26 Yes=21/21 
(100%) 
 ‘Answers don’t always say it 
how I would say it’ 
Were the answers appropriate? 26 Yes=19/21 
(90%) 
‘Answers could be more 
detailed’ ‘Intentionally losing 
weight’- not clear enough 
(n=2) 
Comments on LST appearance? 24 No=15/18 
(83%) 
‘Easy to complete’ 
‘Easy to use’ 
Did LST agree with how the 
patient felt about malnutrition 
risk? 
21 Yes= 17/21 
(80%) 
‘Not at risk but concerned 
about weight’ ‘I lost weight in 
hospital but now am ok’ 
Comments on LST use in 
practice?  
21 No=11/16 
(69%) 
Nil 
Quick and simple to use. 
Further comments 4 4/21 
(19%) 
‘makes me aware that the 
hospital is prepared to provide 
support’  
 
Feedback was considered for future improvements, Table 4.13. 
 
Table 4.13  
Future improvements based on qualitative results  
Improvements based on feedback 
Review wording to focus the NST on intentional weight loss 
Reiterate the importance of the distinction of DI and appetite, within user 
education 
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Consider case scenarios within training, to aid users choosing the appropriate 
risk category, for example regarding recent hospital admissions 
 
Discussion 
5.1 Overview of study results 
The findings would appear to demonstrate that the LST is consistent with DCJ in 
identifying those at risk and those not at risk of malnutrition within the HD patient sample.  LST 
reached high levels of sensitivity (H1) and specificity (H2) that are comparative to current NHS 
diagnostic tests for medical parameters (to be discussed in Section 5.4.1).  A particular strength of 
the Leeds tool was that it maintained comparative efficacy in those that could not fully complete 
the questions (H3), due to dementia, learning difficulties and language barrier.  All of the LST risk 
variables had a relationship with risk of malnutrition, as identified by the dietitian.  In the pursuit 
of a simplified NST, removal of appetite variable produced no change in LST performance (H3) 
and therefore omission should be considered before LST implementation.  Reliability testing 
showed that LST produced consistent results (H4) between different intended users (patients and 
N/S) and in turn, they evaluated LST positively for practical acceptability.   
5.2 Discussion outline 
Within this chapter key study results will be evaluated alongside literature appraisal and 
will consider LST: 
 Transferability 
 Validity and content 
 Reliability 
 Feedback  
This is in fulfilment of the study hypotheses (Section 2.7) and as a necessity of effective NST 
testing (Table 2.1).  
5.3 Sample characteristics 
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Reaching the required sample size means results can be interpreted with confidence.  This 
is with the exception of reliability analysis which involved a small sample, nonetheless it was a 
feature that other authors omit (as commented by Steenson et al., 2013).  Equally presentation of 
sample size calculations, central to research, are also lacking, as summarised by Jones, J. (2002) 
finding only 1/44 NST papers discussed sample requirements.   
The 10% (16/156) that failed to complete was comparable to similar studies by Jones, C. et 
al. (2004) at 20% and Bennett et al. (2012) at 16%.  With only three patients declining to take part 
in this research, LST had a completion rate of 98% (140/143), which is in keeping with the work 
by Lim et al. (2012) and is of primary importance for future NST compliance.  With such a low 
attrition rate (n=16) the sample, recruited from two different units, were thought to be 
representative of the LTHT HD population locally (140/500 HD patients) (See Appendix 10).  
This is fundamental in considering transferability of LST (Appendix2) to LTHT and further afield.  
Sample characteristics appeared to run in parallel for age, gender and co-morbidities with other 
relevant authors (Yamada et al., 2008; Kalantar-Zadeh et al., 1999) and also with national HD data 
(see Table 4.1).  The latter conclusion may be biased by the extent of missing information within 
the research sample (see Table 4.1) and also due to the lack of availability of raw national data, 
statistical testing could not be performed.  Comparisons to national characteristics are therefore 
based on proportions, which is consistent with Steiber et al. (2007) comparing sample 
characteristics to a larger US data set.  
Overall, sample characteristics appear comparable to national HD statistics, especially with 
regards to age, gender and ethnicity (Table 4.1).  Diabetes and cardiovascular disease have an 
observable difference (about 20%), in Table 4.1.  Correlation analysis, however, failed to identify 
a relationship between any of these characteristics and risk of malnutrition (in Table 4.2).  Only 
weight, BMI and weight change correlated, which was anticipated (p= .0001) (see 5.5.1, Appendix 
10).  A larger sample size may detect correlation of other characteristics with malnutrition, with 
varying reports within the literature.  As space is not permitting to discuss finer detail, it would be 
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reasonable to conclude that there was no obvious spectrum bias and transferability of LST to other 
centres could be considered with statistical testing of a larger cohort. 
 
 
5.4- Sensitivity (H1) and specificity (H2) of the LST 
5.4.1 Results as two groups.  Central to this audit is the evaluation of LST performance 
compared with the criterion measure of DCJ.  The need to correctly classify all patients at risk of 
malnutrition and therefore requiring a dietetic referral, takes precedence to ensure that resources 
are directed appropriately (discussed by Ferguson et al., 1999).  There is no generic level of 
diagnostic accuracy, as it is dependent on the test being performed and the consequences of failing 
to identify those at risk.  NHS established sensitivity and specificity levels are set at 70% for many 
medical parameters, including  identification of swallowing problems after a stroke, prediction of 
falls risk and  identification of risk level of ovarian cancer (Scottish Intercollegiate Guidelines 
Network, 2010, p.4; NICE,2013, p.30; Royal college of gynaecology, 2003, p.3, respectively).  
The literature recognises this accuracy cut-off of at 70% for NSTs in the HD setting (Bennett et 
al., 2005, p.145). 
LST achieved a high level of sensitivity (72%) and specificity (100%), particularly as it is 
comprised of mainly subjective variables.  Statistical testing supported these conclusions (Section 
4.3.1), showing moderate agreement and a large association between LST and DCJ results (p= 
.0001).  Furthermore there was a lack of statistically significant discrepancy between both 
methods.   
Sensitivity improved further in the subset of patients that completed all of LSTs risk 
variables (Table 4.3).  Statistical testing continued to show moderate agreement (k=.8) and limited 
statistical difference between methods (p< .001).  
With the accuracy rate of 96%, mis-classification rate of 4% and the observed likelihood 
ratio (Table 4.4) the LST appears to have functional value (Cooper et al., 2002, p.131).   
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MUST has demonstrated higher levels of accuracy, 93% sensitivity and 100% specificity 
in 400 hospital patients however this study excluded patients with ESRF (Ferguson et al., 1999).  
These results are not transferable to the study setting, as discussed in Section 2.4, as MUST has a 
heavy reliance on objective measures, which undermine its diagnostic ability in HD patients.  
Furthermore this sample had relatively low levels of malnutrition (16%).   
SGA has shown increased sensitivity compared to the current study, with 83% sensitivity 
and 93% specificity, however this was based on the comparison of SGA with an expanded version 
of itself (PG-SGA) and was in a small sample size (Desbrow et al., 2005).  Further bias was 
introduced by the researcher completing SGA from the PG-SGA answers.  This high level of 
sensitivity is not consistently shown for SGA however, as described by Gurreebun, Hartley, 
Brown, Ward & Goodship. (2007) who reported SGA to have a sensitivity of 32% to the criterion 
measure which was BMI (<23kg/m2 signified at risk), albumin or weight loss (of >5%), which in 
isolation are not substantiated criteria and may explain the particularly poor performance.   
Even though comparable to other research, 72% sensitivity in the current study means that 
28% of patients requiring referral would fail to be identified.  In terms of referrals, 25 patients 
from the LTHT HD population would be missed by the LST compared with DCJ at any one time 
(Table 4.5).  These patients may also be told that they were not at clinical risk of malnutrition, 
thus allowing malnutrition risk to progress.  The advocated monitoring and repeat NS for 
nutritionally vulnerable patients (set at three monthly by the LTHT team, or as clinically 
indicated) means that  HD patients that are missed are not overlooked (recommended by NICE, 
2006; RA, 2010).  LST also improves upon the current uncoordinated dietetic referral system 
which generated 39 referrals in the last quarter, equating to 43% of those identified by DCJ and 
therefore failing to refer 51 patients.  Table 4.5 is provided for illustrative purposes, showing these 
figures calculated up for estimated annual referrals within LTHT and at a national level.  
Ultimately however, these figures are presumed to be an overestimation, as at repeat screening a 
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number of the cohort would already be under dietetic care and nutritional improvements may 
reduce the risk level observed.  
Implementation of LST would not only lead to an increase in dietetic referrals, estimated at 
17%, but the system would be more likely to generate appropriate referrals.  Oakley and Hill 
(2000) report estimated referral rates, at 77%, on future implementation of an NST within a 
hospital ward.  These results appear particularly high and may have been skewed by the fact that 
scoring and wording was altered part way through and retrospective data was included.  These 
anticipated referral rates therefore require monitoring, alongside analysis of cost-effectiveness 
versus clinical outcome improvements, which is a key area needing research (BAPEN, 2005; 
NICE, 2006).  The LST high level of specificity is important as it suggests that wasting finite 
resources would be kept to a minimum. 
5.4.2 Results as a four point scale.  Analysing results as two categories defeats the 
rationale for having multiple strata with differing dietetic actions for each category (as outlined by 
Campbell et al, 2007).  Therefore consideration must be given to accuracy along the extended four 
point scale (Figure 4.2).  Statistical testing shows conflicting results for LST across 4 risk levels, 
on the one hand there was a high association between each method across each risk level (p< .001) 
and there was a failure to identify statistical discrepancy at each point (p= .11).  Conversely, 
agreement analysis showed that there was only fair consistency (k=.48) (p< .001).  The latter may 
be explained by the results in Figure 4.3 and Table 4.6, whereby there was a good level of 
accuracy 89% to 98% across all levels except for those in the severely at risk group (at 1/7, 17%), 
thus skewing results.   
60% of discrepancies were based on subjective differences between LST and DCJ (Figure 
4.4), mainly due to how the patient perceived answers (consistent with Cooper et al., 2002).  For 
example, patients perceived their DI to be better than that assessed by the dietitian (described by 
Cupisti et al., 2010).  Despite these discrepancies, overall LST had high levels of accuracy, 
especially in the early stages of malnutrition risk, where there is proportionately a larger number.  
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Bryan et al. (1998) explain that subjectivity of staff is more accurate in patients with chronic 
conditions, due to the frequency at which the patients are seen.  De Mutsert et al. (2009) advocate 
training as an integral part of NS, to enrich understanding of the nutritional parameters in ESRF.   
Accuracy results do however suggest that further work is required in testing LST in a 
larger sample, particularly in those at severe risk.  The low rates of severe risk are comparable to 
similar studies, see Table 5.1, even in a larger sample (de Mutsert et al., 2009) (n=1601).  
Table 5.1  
Literature based incidence rates of risk of malnutrition  
Study Assessment 
method 
Sample 
size 
N= 
No 
risk  
(%) 
Low 
risk 
(%) 
Mild to 
moderate 
Risk (%) 
Low to 
moderate 
combined 
(%) 
Severe 
risk 
(%) 
This study DCJ by dietitian 140 53 29 13 42 7 
This study LST by CSW 140 58 29 12 41 1 
Cooper et 
al. (2002) 
SGA by 
dietitian 
76, 52 
HD 
patients
58   34 8 
Visser et 
al. (1999) 
SGA as a mean 
of 2 N/S 
22, 13 
HD 
patients
64   27 9 
De 
Mutsert et 
al. (2009) 
SGA by >76 
N/S in 38 
centres  
1601 72   13 5 
 
There was a 20% incidence of risk of malnutrition within LTHT, based on DCJ and this 
compared with 13% by LST, determined by the referral cut-off point decided by LTHT dietitians 
(Table 4.7).  Nutritional studies often incorporate low to severe risk (Table 5.1) and so with this 
guidance the incidence rate at LTHT increases to 49% based on DCJ and 42% by LST.  These 
levels are comparable to literature established rates.  Cooper et al. (2002) and Visser et al. (1999) 
report a proportionately lower risk than the current study, this may be attributed to their inclusion 
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of HD and peritoneal dialysis patients, with the latter dialysis group being less nutritionally 
deplete on dialysis treatment over time (Jager et al., 2001).  De Mutsert et al. (2009) also report a 
lower incidence of risk and this may be as a result of it being a comparatively large study, based in 
the Netherlands and with baseline differences in ethnicity (92% white) as compared with the UK 
HD and study population (in Table 4.1).  The authors deduced dietetic intervention before patients 
reach ESRF contributed to low rates.  Consequently, this highlights NS as a priority in the early 
stages of ESRF and that a prompt dietetic referral should be triggered earlier, in those at low risk 
(a score of two as opposed to three).   
5.4.3 Summary.  Sensitivity and specificity results support H1 and H2 and oppose H0  
5.5 Risk variables in LST completion (H3) 
  Nine percent (13/140) of HD patients were unable to converse, due to dementia, learning 
difficulties and language barriers.  Despite the subjective risk variables not being completed (A to 
D) the sensitivity and specificity of LST remained at a modest level (67% and 100% respectively) 
(p= .005).  This analysis should be considered with caution as numbers were small and only three 
were at risk (See 4.4.1).  As this is a minority HD section, calculations estimate that eight patients 
would be at risk, based on DCJ and three patients would fail to be referred by LST.  Representing 
this patient group is a distinct feature of this study, with many other studies simply excluding them 
(as seen in Yamada et al., 2008).  One study gave those unable to answer an immediate referral 
and thus may be wasting resources (Ferguson et al., 1999).  Although LST is not equally as 
effective as fully completed tools, supporting H3 and opposing H0, it provides a starting point for 
future work and through the process of NS these patients would be monitored at regular intervals. 
5.5.1 LST risk variables.  Considering the appropriateness of risk variables contained 
within LST (Appendix 2) is an important aspect, due to the lack of defined nutritional parameters 
for NST inclusion in the HD setting.  The results in table 4.8 show that all of the nutritional risk 
variables within LST individually correlated with risk of malnutrition as determined by DCJ.  All 
of the results were highly statistically significant (p<.001).  Both objective and subjective risk 
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variables provided an important contribution in the identification of malnutrition risk (an average 
of 40% and 29%, based on Table 4.8). 
Both correlation (Table 4.8) and multiple regression (Table 4.9) analysis highlighted 
weight loss, BMI, DI and PA most favourably (see Appendix 10, model 4, SE=±0.4).  In 
conjunction these four risk variables had a 90% overlap with DCJ (P<.001), which is 
comparatively better performance than the literature.  Enia et al. (1993) for example, found that 
the nutritional measures within their study correlated to 56% of risk of malnutrition, as determined 
by SGA. 
In the present study the objective measures BMI and weight loss (variable E & F) 
correlated the most with risk of malnutrition, Table 4.8 - 4.9.  This is an anticipated result, as the 
at risk group showed a statistical difference in weight (by 15kg), BMI (by 5.3kg/m2) and weight 
loss (by 6.4kg, p= .0001).  Bennett et al. (2012) supported this conclusion, finding a 10.8 kg 
reduction of weight in the at risk group (p= .04).  Equally, Cooper et al. (2002) reported a 
statistically significant 3.2kg/m2 reduction in BMI in those at risk (p .0001).   
Results show that weight loss and BMI, do however require DI and PA in combination to 
produce the most effective version of LST.  Furthermore, based on clinical observation LTHT and 
UK renal units vary in  their quality of fluid management based on staffing, expertise and 
equipment availability and therefore the accuracy in estimating flesh weight and in turn 
percentage weight loss and BMI is presumed to be variable due to the complexities involved.  The 
inappropriate or lack of adjustment for fluid weight may explain why some authors struggle to 
identify statistical difference with BMI , as seen in the study by Lawson, C. et al. (2012) when 
using MUST in a renal population.  Equally, Enia et al. (1993) found limited correlation with 
weight loss and risk of malnutrition, there was observed fluid retention in those at risk and thus the 
fluid may have masked any flesh weight loss.  Electronic aids may improve NST sensitivity and 
speed up NST completion (Elia & Stratton, 2011), but this is reliant on appropriate weight 
adjustments being inputted. 
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There are further limitations with BMI as a sole diagnostic measure (Janardhan et al., 
2011) as its cut-offs may vary; in patients from Asian heritage, the older adult, patients with 
amputations and muscular patients (Kovesdy & Kalantar-Zadeh, 2012).  Therefore using BMI in 
an NST for a population with mixed patient groups may mean sensitivity of the NST fluctuates.  
Figure 4.5 illustrates that any BMI can be at risk of malnutrition and not just below a specific 
value recognised as 23kg/m2 in the literature (Kovesdy & Kalantar-Zadeh, 2012).   
Despite the limitations of the objective measures, 80% of patients with a BMI of less than 
23kg/m2 and a weight loss of >5% fell into the at risk group, therefore demonstrating the 
importance of their inclusion.  Subjective measures of patient perceived weight change adds 
another perspective on weight and within this study provided the highest unique contribution to 
identifying risk of malnutrition (Table 4.9).  Ferguson et al. (1999) do however warn that patients 
are commonly unsure of the extent of weight change and ultimately, it is the evaluation of both 
objective and subjective weight variables that improved LST accuracy.   
PA appeared to highly correlate with predicting the risk of malnutrition (r=.68) (p< .001) 
(Table 3.8).  Due to the subjectivity associated with defining nutritional related changes in PA, 
some authors alter the question, despite providing workshops for NST guidance (de Mutsert et al., 
2009).  It is interesting to note that there was no statistically significant correlation between BMI 
and PA within the current study, suggesting that the CSW was able to appropriately distinguish 
signs of wasting without relying on BMI to assess PA.  This may suggest that the guidance 
provided at the outset of the study aided subjectivity within PA.   
DI had a moderate correlation with risk of malnutrition (r=.4) (P<.001) (Table 3.8), which 
is consistent with Cupisti et al. (2010), although their conclusions were limited with only three 
patients at risk.  Furthermore, the current study showed that poor DI moderately correlated with 
the long-term marker of nutritional status, BMI (p= .04) (consistent with Jones, C. et al., 2004). 
Appetite provided contrasting results to DI, which echoes the distinction made by 
Kalantar-Zadeh et al. (2004) that these variables are separate entities.  Appetite was consistently 
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the weakest variable, contributing 16% to risk of malnutrition.  Kalanatar-Zadeh et al. (2004) 
explained that 20% (66/331) of HD patients had a variable appetite across one week and so these 
observed fluctuations in appetite, as opposed to prolonged symptoms, may explain why there is a 
reduced link with malnutrition risk.  Figure 4.6 illustrates that appetite does not follow a trend and 
in keeping with this, results showed a failure to detect a correlation with BMI in the longer term 
due to its transitory nature.  Burrowes et al. (2005) also reported that a poor appetite did not 
associate with a reduced BMI (p= .11), although this study only considered appetite over the 
previous week.  
Along with being the statistically weakest variable, appetite contributed to 24% (9/37) of 
the discrepancies (Figure 4.4).  Removal of the appetite variable from LST, in the pursuit of a 
simpler tool, had no significant effect on sensitivity and specificity (p= .0001). 
5.5.2 Summary.  LST is not as effective when it is not fully completed, supporting H3 and 
opposing H0.  That being said, not completing or in fact removing the appetite risk variable had no 
effect on LST effectiveness. 
5.6 Reliability of LST (H4).  
There was a high level of consistency in measurements between the CSW, the patient and 
the nurse (Table 4.10-4.11).  However due to the low numbers used in reliability testing, with only 
two patients at risk, further investigation is needed to assess efficacy in user groups.  Equally 
results are limited for carer completed LSTs, due to the numbers involved and as all patients fell 
within the not at risk category. 
Despite reliability testing being completed in a small sample, the study made efforts to 
consider the perspectives of differing user groups, unlike many authors (concluded by Jones, J. 
2002).  Ferguson et al. (1999) provide a biased example of reliability, as although they found a 
substantial agreement between a nutrition assistant and a dietitian in 32 patients the NST only 
encompassed three questions and the researchers were not reflective of intended users.   
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5.6.1 Summary.  It would appear that LST is reproducible between future users, 
supporting H4 and opposing H.0 
 
5.7 LST feedback 
The LST evaluated to be clear in its meaning, appropriate, easy to complete and practical, 
based on the user feedback (Table 4.12).  As a fundamental component of NST testing, feedback 
is something that only a few other researchers have achieved (including Weekes et al., 2004). 
Improvements based on feedback, in Table 4.13, mainly extended to training.  
5.8 Improvements 
There are five main areas for study improvement; 
 First, the method of DCJ should be based on face to face contact within the required 
sample size, as opposed to a combination of direct contact or evaluation of records.  The 
varied technique of obtaining DCJ in this study may have diluted results, as patients that 
had direct contact had an increased sensitivity (to 75%, p<.001). 
 Second, DCJ and reliability testing should have been completed over a shorter time frame, 
within hours of LST.  Varying lengths of time between methods not only provides 
inconsistencies in method but may also minimise the accuracy of the NST in a population 
where symptoms and appetite fluctuate.  
 Third, data collection needs to continue for increased precision, so that an increased 
number of patients at risk of malnutrition can be analysed (see Appendix 7).  Further 
reliability studies are also required.  
 Fourth, increased staff guidance on interpreting patient answers may reduce respondent 
bias and improve LST accuracy.  For example, patients may tell the health professional 
what they think they want to hear or the patient may unknowingly underappreciate or 
overestimate the answers.  Training, similar to that required for MUST, is fundamental in a 
tool that is based on subjective questions. 
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 Finally, to run parallel with the quantitative data collection, a qualitative approach drawing 
on focus groups or case-studies may provide other perspectives. 
 
5.9 Implications 
The current study provides value and originality of an NST that has been designed and 
tested in a representative HD population, with the particular feature of involving intended future 
user groups.  LST would appear to demonstrate that it is comparable to other NHS diagnostic tests 
and indicates that it could efficiently facilitate the targeting of resources to those in need.  This 
research raises awareness of the nutritional vulnerability of the HD population and of NS as a long 
term NHS cost-saving in a climate of increased pressure on resources.  Implementation at LTHT 
will be considered on dissemination of results to the dietetic and renal team.  This work provides a 
platform for future studies and is to be considered as part of multicentre research by the national 
Renal Nutrition Group.  The work will also be shared with the BDA and British Renal 
Symposium.   
5.10 Future 
The current study calls for accepted gold standard diagnostic and assessment criteria for 
risk of malnutrition in the HD setting.  A recognised method would aid dietetic assessment, study 
comparisons and national and international data collation.  
Monitoring the value of an NST implementation is a fundamental consideration for future 
research.  This would encompass cost-benefit analysis of nutritional, clinical and economic 
outcomes associated with each risk category (as discussed by NICE, 2006).  Further auditing 
cycles would be required on implementation to consider intervals of NS and the excluded dialysis 
patient groups; paediatrics, home HD and peritoneal dialysis, that are without an NST. 
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Conclusion 
 With the rates of risk of malnutrition established at 49% within the LTHT HD population, 
the relevance and usefulness of LST for identifying those that require dietetic intervention 
cannot be disputed.   
 In answer to the question, the Leeds tool demonstrated that it could identify those patients 
at risk of malnutrition, that it was consistent with the dietitian and comparable to other 
NHS diagnostic tests.  In turn, resources would be directed appropriately and timely.   
 The LST also provided functional value within the subsection of patients that were unable 
to fully complete the NST questions.  
 Implementation of an NST programme advocates NS at regular intervals and so those, 
about a third, that the LST did not correctly identify to be at risk, would be monitored 
regularly.   
 At the centre of LST performance was a combination of objective and subjective 
nutritional risk variables.  These variables were valid and comprehensive in the HD 
setting, which has proven to be a challenging find for many researchers.  
 In the pursuit of a simpler NST, the appetite variable could be removed, without reducing 
effectiveness.   
 The tool’s dependence on subjective variables does mean that effectiveness will vary 
depending on the user and therefore a basic education session is fundamental in enhancing 
accuracy.   
 The LST did appear to be consistent with future users and feedback demonstrated LST to 
be acceptable, quick, easy and understandable.  The extent and quality of the feedback 
gained within the study was disappointing and should be addressed in further work.  
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 Despite the need for future methodological improvements, the current research 
endeavoured to fulfil the requirements of effective NST development and testing.  As a 
result of the varying quality of nutritional studies within the literature, this research 
provides improvement on studies within the HD setting.   
 This study therefore provides a robust NST for a sensitive patient environment and a 
framework for future research within a larger regional cohort.   
 Ultimately, this study raises awareness of the nutritionally fragile HD population and it 
also contributes to work that has been identified as a priority nationally and internationally.  
The results will be disseminated to LTHT renal team and considered for implementation.  
 Further research would be required to determine transferability of the Leeds tool and to 
consider the effect of NST implementation on clinical and cost outcomes, with the 
overarching goal of reducing prevalence of malnutrition 
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Appendix 1. Executive summary of the previous LST audits. 
 
 
Audit 1 to 4 Overview 
Overall response 
rate 
99% (1/28 patients declined) 
Incidence of 
malnutrition 
risk 
43% (as per random sampling in audit 2)  
Reference 
standard 
SGA showed poor agreement with dietetic clinical judgement (in only 31%), compared to 
LST version 1 (at 68%).  SGA was also 2 risk categories apart from the reference standard 
in 15% of cases in audit 1.  In audit 2 25% of SGA referrals were inappropriate.  SGA was 
also discredited by the feedback that wording was complicated and ‘jargony’ and the tool 
was more time consuming. 
Barriers  28% of the sample could not converse to provide answers. 
Only 12% were able to self-complete the tool. 
 
A full report is available on request. 
 
 
Audit/tool 
number 
Tool development Haemodialysis 
sample 
Reference method Additional testing 
Audit 1 
Version1 
Initially created based on the 
literature, screening tools in 
circulation and clinical 
experience.  
Known to be at 
risk, on dietetic 
books 
N = 14 
Both dietetic 
clinical judgement 
and SGA 
Nil 
Audit 2 
Version 2 
Version 2 modified on audit 1 
results;  
-Altered BMI cut-offs 
-Improve wording 
-Remove functional ability, 
dialysis years, co-morbidities and  
GI symptoms 
- Add question for appetite 
Random 
N = 14 
Both dietetic 
clinical judgement 
and SGA 
Small scale nursing 
and patient 
involvement in tool 
completion, 
including their 
feedback 
Audit 3 
Version 3 
Version 3, modified on audit 2 
results; 
-Remove biochemistry 
-Improve wording 
-Training as a precursor for tool 
use 
Nil Nil Renal dietetic 
colleague semi-
structured 
questionnaire 
feedback 
Audit 4 
Version 4 
Version 4, modified on audit 3 
recommendations; 
- Consent and introduction 
-Improve wording 
- Change scale 
Nil Nil LTHT Patient 
Information Group 
review  
Audit 5 = 
Masters 
study 
Version 5, tested in the current study based on a tool modified on audit 4 recommendations; 
-Move BMI 
-Identify staff completion sections 
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Appendix 1. Continued. Justification of changes made during the LST audits. 
The tool 
 
 
 
 
Introduction Consent options need to be included, alongside an introduction (as version 4). 
Language- 
 
72% renal dietitians felt that the language should be more patient friendly for 
version 5.  For example, patients often did not know their weight loss in 
numerical terms, considering clothing size, body size, body shape changes 
and using signs and symptoms may be simpler.  Using portions, specific 
timeframes and objective measures may be easier for the patient to decipher 
the appropriate risk category (altered for weight change, appetite and dietary 
intake questions).    
Scales- 
 
100% dietitians felt the tool should be simplified by using a scale of 1 to 4 
rather than 1 to 5 (actioned from version 5).  Audits showed that averaging 
scores worked well, particularly when not all questions could be completed. 
Equal weighting for each risk variable appeared to be appropriate. 
Format- The tool, layout and font was well received by nursing staff and patients in 
audit 3.  Feedback was positive; ‘User friendly and easy to get to grips with.’  
Practicality Considerations As patients are all routinely seen twice by the dietitian within the first 3 
months of dialysis, it was agreed in audit 3 that the patients will only be 
screened after the first 3 months, 3 monthly thereof.  Computer calculated 
objective data would be beneficial.  As per audit 4 feedback, a training 
package is required before implementation, to equip the tool user with the 
appropriate interpretation skills. 
Inclusion 
criteria 
Intake & 
appetite 
Fluctuations in appetite and intake appear to be common and therefore are an 
important variable to include.67% patients scored appetite and dietary intake 
differently in audit 2, suggesting the patients identify these as different 
entities. 
Weight Altered BMI cut-offs improved appropriate scoring in audit 2.  A couple of 
patients commented that they were unsure ‘what BMI meant,’ therefore the 
objective questions have been shaded and moved to the bottom, which the 
staff can complete (this was also highlighted in audit 4).   
The dietitians agreed that Target weight is the most reliable weight to use.  
Calculating percentage weight loss by the user, plus the patient commenting 
on weight change, as 2 questions (as in version 5) add strength and improve 
problems found with patients underestimating weight loss due to fluid bias.   
Physical 
appearance 
A question on physical appearance was 100% useful in reinforcing 
appropriate scores in audit 2.  It also helped in 75% who could not be 
conversed with.   
Exclusion 
criteria 
Functional 
ability 
 
Appeared as a challenging question, due to difficulty associated with 
pinpointing the contribution of nutritional deficit in decline.  Removal of this 
question improved scoring by 91%.  Interestingly only 30% of those known 
to be malnourished in audit 1 felt that they had a reduction in functional 
capacity. 
HD vintage & 
comorbidities 
Audit 1 & 2 showed that dialysis vintage and co-morbidities affected the 
results inappropriately in 100%.  60% patients were unable to detail answers. 
GI symptoms In 65% this question affected scoring inappropriately, as although symptoms 
were frequently experienced they did not necessarily affect intake. 
Biochemistry None of the biochemical parameters closely mirrored the expected 
relationship seen with advancing risk of malnutrition.   
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Appendix 2. LTHT Nutritional Screening Tool (LST)                                        Patient number………NHS Number…….………     
 
Patients on dialysis can experience problems with their appetite and eating.  By completing the following questions every 3 months it will highlight if you are at risk of malnutrition, so 
that the dietitian can help to support you with this.   The questions can be completed by a clinical support worker or a nurse with you, or you can complete the questions on your own.   
If you do not know the answers to the following questions please leave the questions blank.   
           CONSENT……...Y/N                    DATE ..…..………….                     COMPLETED BY (name and position)……………………….. 
Circle the relevant number for A to E below.   
If you do not know the answers to the following questions please leave the questions blank. 
A. Patient reported weight change - Have you noticed any unintentional flesh weight loss over the last 6 months?  
1 2 3 4 
No recent change in flesh 
weight 
 
2-4lbs/1-2kgs and no previous 
history of significant flesh weight 
loss 
or longstanding habit of flesh 
weight going ‘up and down’ 
Over ½ stone/ 3kg weight loss 
over the last 3-6 months,  
may be due to recent period/s of  
being unwell 
or a drop in a clothes size 
Large weight loss of more than a 
1stone/ 6kg, over the last 3-6 
months, may be due to a long 
period of being unwell 
or more than 1 drop in clothes size 
B. Dietary Intake-Has your noticed any changes in your eating recently?   
1 2 3 4 
Eating well, 
  ‘I think I am eating enough’ 
 
Less than usual for less than 2 
weeks but now improving  
or ‘I have never been a big eater, 
but I don’t miss meals’ 
  ‘I am eating 50% of my meals in 
the last week or more’ 
or  ‘No change but I don’t think I 
eat enough and I do miss meals 
some days’ 
Eating is very poor for more than 
a few days 
or ‘I can’t  face eating a lot of the 
time’ 
C. Appetite- How would you describe your appetite at the moment?   
1 2 3 4 
‘No change, good appetite’ ‘up and down, but I always make 
myself eat’ 
‘ It varies, sometimes I do 
struggle with my appetite and my 
eating can suffer’ 
‘Poor appetite most of the time,’ 
‘not interested in food a lot of the 
time’ 
D. Physical Appearance-Do you feel your body shape or size has changed recently?  Answer the question jointly with the patient. 
1 2 3 4 
No change, appears well 
nourished 
Slim but ‘always been this way’ Some signs of reduced fat and 
muscle stores 
Obvious signs of fat and muscle 
wasting  
E.  BMI- to be completed by a staff member and is calculated by BHLY. 
1 2 3 4 
 Greater than 25   24.9 to 20.1 20.0 to 18.6 Less than 18.5 
F. Percentage weight loss - over 3 months,   to be completed by a staff member and is calculated by BHLY 
1 2 3 4 
weight gain or less than 2.0% 2.1-4.9%  5.0-9.9% Greater than 10.0% 
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After answering the above questions an ‘average score’ is needed 
 
It maybe that some of the questions were unknown or unavailable.  For example you may find it difficult to grade physical appearance in question E.  
Especially for those patients that are very slim, as they may have been slim for many years and are not malnourished.  Equally in those that are very 
overweight, wasting maybe be hidden.  Therefore it is important to ask the patient how they feel about their appearance. 
To create an average score, the scores circled need to be added together and divided by the number of questions answered. 
EXAMPLE- If a patient does not speak English, it may be that only D, E & F can be answered. 
In this case scores 2+3+4 = 9 as a total score.  9 (total score) divided by 3 (questions) provides the average score of 3. 
 
Once an ‘average score’ is calculated, the following screening care plan should be commenced……. 
 
 
 
 
 
 
 
 
 
 
 
Date Average 
score 
Screening care plan
 
Action required 
√or X 
Action complete 
√or X 
Signature & position 
  
 
 
1.Repeat screening only 
2.BCM 
3.Dietetic referral 
    
 
  
Score 1-2 = No risk or low risk of malnutrition 
No dietetic intervention required.  Repeat Screening tool in 3 months.  
Consider if there is a highlighted need for a BCM
Score 4 = Severe risk of malnutrition 
Inform patient of the results and gain consent before completing a dietetic 
referral.  Consider if a repeat BCM is required. 
The patient will be seen within 1 week
Score 3 = Mild and moderate risk of malnutrition 
Inform patient of the results and gain consent before completing a dietetic 
referral.  Consider if a repeat BCM is required. 
The patient will be seen within 2 weeks 
This action should agree with your clinical judgement 
Screening care plan 
 Please see the dietetic referral form for other dietary referrals;  
 Including…. 
 - Renal dietary advice and support (for potassium, phosphate, salt, fluid) 
 - Therapeutic dietary advice; coeliac disease, diabetes  
 - Weight management advice, for example for transplant 
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Appendix 3a. Malnutrition Universal Screening tool (permission gained, see Appendix 5) 
Retrieved from http://www.bapen.org.uk/pdfs/must/must_full.pdf 
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Appendix 3b. Subjective Global Assessment tool 
(Taken from Steiber et al., 2004, p. 195, permission gained, see Appendix 5) 
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Appendix 4. Dietetic Clinical Judgement Standard 
Consider each of the following criteria (1-7) to identify risk of malnutrition, scoring is based on 
the…….    
The risk category continuum 
 
 
 
 
Consider the criteria below, to provide risk category score, which will serve as the dietetic clinical 
judgement criterion measure. 
Criteria 1 Anthropometric Data 
MUAC/TSF/HGS 
Physical appearance 
Comments 
 
Criteria 2 Weight 
BMI 
Weight History 
Unintentional weight loss 
Look at target weight, 
bioelectrical impedance 
Comments 
 
Criteria 3 Dietary Assessment 
Using last assessment 
Appetite  
Intake 
Requirements 
Deficit 
Dietary restrictions 
Time on dialysis 
Problems with eating  
Symptoms 
Comments 
 
Criteria 4 Nutrition support 
Recent nutritional support 
need 
Food fortification 
Nutritional supplements 
IDPN 
Comments 
  
Score 1 2 3 4 
Risk No Low Mild and moderate Severe 
0300006 
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Criteria 5 Social/ Mental Conditions affecting Intake 
 Mood, confused 
 Neglect 
 Depressed  
 Stress 
 Lives alone 
 Reduced social 
contact 
 dementia 
 Quality of life 
 Social constraints 
 Age and ability with 
food 
 
Comments 
 
Criteria 6 Medical Conditions affecting nutritional status 
 Medical Conditions 
Affecting  
Polypharmacy 
Medical letters 
Recent admissions 
Treatment plans 
Pain 
Dialysis 
Comments 
 
SGA score 
7 = no risk 
6 = low 
3,4,5 = mild and moderate 
1-2 = severe 
 
 
Comments 
 
 
 
 
 
Overall risk category = 
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Appendix 5. Permission 
Permission for figures used. 
 
Permission for figure 2.1 
From: kim bowra  
Sent: Monday, August 18, 2014 6:16 AM 
To: Franch, Harold A 
Subject: Request 
-Hello 
I am wondering whether I could have your permission to copy the diagram of the etiology of PEW 
(p78) from your paper Etiology of the Protein Energy Wasting Syndrome....'in my masters work 
(unpublished) regarding development of a nutritional screening tool in the HD population. 
Many thanks 
Kim Bowra 
 
‐Franch, Harold A 18/08/2014  
To: kim bowra  
Yes, You may use the figure as long as the work remains unpublished.  If published, you will need to go 
through Elsevier.  
 Good luck 
 
 
Permission corresponding to MUST tool (Appendix 3a) 
To: bapen@bapen.org.uk 
Subject: MUST‐permission 
Hello 
I am a renal dietitian in Leeds and I am currently completing my Masters 
I would like to reference a copy of the MUST tool in my Appendix, which I can copy from your 
website  
Is that ok?  It will not appear in a published paper 
Thankyou 
Kim Bowra 
 
 
Hi Kim 
I can confirm that this is fine. 
Kind regards 
Correen (BAPEN Office) 
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Permission for SGA (appendix 3b) 
‐Using researchgate (https://www.researchgate.net/messages/179840699) 
‐I am currently completing my Masters and I would like to use the KDOQI model of SGA from your paper 
'subjective global assessment in chronic kidney disease; a review' in my appendix. 
Would that be ok? 
Many thanks 
Kim Bowra 
Renal dietitian 
‐Sure that is great. 
Best wishes 
Alison 
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Appendix 5. Continued. Permission. 
NHS Research and Development letter (received by email) 
 
 
 
 
Kim Bowra 
Renal Dietitian 
Leeds Teaching Hospitals NHS Trust 
 
Research & Innovation Directorate
34 Hyde Terrace
Leeds
LS2 9LN
Tel: 0113 392 2878
Fax: 0113 392 6397
www.leedsth.nhs.uk/sites/research_and_development 
 
  17th January 2014 
    
 
Dear Ms Bowra, 
 
An audit to test if the LTHT nutritional screening tool can identify haemodialysis patients at 
risk of malnutrition. 
 
Thank you for asking me to review the above study. 
 
After reviewing your project, it is my opinion that it falls into the NHS category of "Service 
Evaluation/Development", rather than "Research". As such, it does not require NHS Research 
Ethics or R&D approval. It will require managerial approval within the Trust 
Directorate/Clinical Service Unit where the study takes place. 
It is, of course, important to ensure that you meet all the requirements for patient confidentiality, 
data protection and information governance. The best way to do this is to pseudoanonymise the 
data you collect and analyse. It would also be good practice to seek written informed consent from 
the patients who take part.  
  
 
Yours sincerely, 
 
 
 
Dr Derek R Norfolk 
Associate R&D Director 
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Appendix 5. Continued. Permission.  
Consultant Clinical Service Unit approval (received by email) 
 
Department of Renal Medicine 
 
St James's University Hospital
Beckett Street
Leeds
LS9 7TF
 
Tel: (0113) 243 3144
www.leedsth.nhs.uk
Direct Tel: (0113) 206 4534
TO WHOM IT MAY CONCERN 
 
Direct Fax: (0113) 206 4111
Date Dictated: 21 Jan 2014
Date Typed: 21 January 2014
Our Ref: EJD/SH
 
 
Dear TO WHOM IT MAY CONCERN 
 
 
Dietetic Audit - Nutritional Screening - An Audit to Test if Nutritional Screening Tool Can 
Identify Haemodialysis Patients at Risk of Malnutrition 
 
This letter is to confirm that we are happy for Kim Bowra, Renal Dietician, to undertake the above 
audit of haemodialysis patients receiving treatment in the Leeds Teaching Hospitals NHS Trust. 
  
Yours sincerely 
 
 
Electronically signed by 
Dr Emma Dunn 
Consultant Nephrologist 
 
 
 
 
 
Chairman Mike Collier CBE   Chief Executive Julian Hartley 
The Leeds Teaching Hospitals incorporating:  
Chapel Allerton Hospital   Leeds Dental Institute   Seacroft Hospital 
St James’s University Hospital   The General Infirmary at Leeds   Wharfedale Hospital 
 
 
 
 
0300006 
 
  89
 
 
Appendix 5.Continued. Permission. 
 Nursing Clinical Service Unit approval 
                                                                                                            
To Whom it May Concern 
 
 
 
 
              Direct line: 0113 2064947 
 
           Email: Beverley.craggs@leedsth.nhs.uk 
 
                   28 January 2014 
 
 
 
Dear Sir/Madam 
 
An audit to test if the LTHT nutritional screening tool can identify haemodialysis patients at 
risk of malnutrition. 
Kim Bowra - Renal Dietician 
 
I write to confirm that I give permission for a Clinical Support Worker working 30 hours per week for 
the above Project and that nursing involvement will be based around working practice. 
 
If you need any further information, please do not hesitate to contact me. 
 
 
 
 
Yours sincerely 
 
Beverley Craggs 
Matron - Hepatorenal Services 
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Appendix 5. Continued. Permission.  
Funding letter-LTHT Charitable foundation 
                                                                                                     
Tel Enquiries: Tara Bain (0113) 206 7358 
E-Mail: tara.bain@leedsth.nhs.uk 
Ref: BM/TB/LW 
Date:08 August 2013 
 
Dear Kim 
Chief Nurse Education Fund - Charitable Foundation  
 
Thank you for your application to support the ‘Masters Qualification in Nutrition and Dietetics’’ Course that 
you wish to undertake. 
 
I am pleased to inform you that the Charitable Foundation will provide 75% (£1237.50) for the current 
academic year (2013/ 14) in support of your application. The remaining 25% of the fees should be met by 
yourself.  
 
In order to access these funds, you will need to forward me an original invoice from the attending University.  
This invoice should be forwarded to Tara Bain, Nursing Directorate, at the above address.  Once this 
invoice is received a cheque will be raised and sent directly to the attending university along with the 
original invoice.  Alternatively you can pay for this course yourself and then forward your invoice with receipt 
to Tara Bain at the above address, we will then reimburse you by raising a cheque in your name and 
sending it to your home address (please ensure you notify me of this). It will be your responsibility to pay the 
invoice in full.  Will you please liaise with your Course Provider to ensure you are able to produce the 
invoice no later than September. 
 
Please note that the funding is for course fees only.  Reimbursement for travel expenses, accommodation 
and books, if appropriate, will be subject to negotiation with your manager. 
 
If you have any queries, please do not hesitate to contact me. 
May I take this opportunity to wish you well with your studies. 
 
Yours sincerely, 
 
Bob McMaster 
 Lead Nurse – Workforce & Education 
 
 
 
 
 
Chair Linda Pollard CBE      Interim Chief Executive Chris Reed 
The Leeds Teaching Hospitals incorporating: 
Chapel Allerton Hospital     Leeds Dental Institute    Seacroft Hospital   
St. James’s University Hospital   The General Infirmary at Leeds    Wharfedale Hospital 
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Appendix 6. Patient Information Sheet 
 
  
An audit to test if the LTHT nutritional screening tool can identify 
haemodialysis patients at risk of malnutrition. 
 
You are being invited to take part in a clinical audit.  Before you decide, it is 
important for you to understand why the research is being done and what it will 
involve.  Please take until your next dialysis session to read the following 
information and discuss it with others if you wish.  Please ask if there is anything 
that is not clear or if you would like more information.   
The following information can be read to you or left with you to read alone.  Please 
discuss your preference with the researcher who approaches you, the sister on the 
unit (Sarah Simpson) or the researching dietitian (Kim Bowra). Thank you for your 
time. 
What is the purpose of this study? 
There are many guidelines that recommend the use of a nutritional screening tool to 
identify if patients receiving haemodialysis treatment are at risk of malnutrition.  If a 
patient is highlighted to be at risk of malnutrition a referral to the dietitian for 
dietary assessment is then prompted. 
Currently there are only general screening tools available, which cover a wide range 
of conditions but are limited in patients on haemodialysis. 
The LTHT screening tool has been developed with information from the literature 
and from 4 previous small scale audits, which has involved previous patient and staff 
feedback.   
The aim of this audit is to test whether the LTHT nutritional screening tool agrees 
with dietetic clinical judgement in identifying whether you are at risk of malnutrition 
or whether you are not at risk of malnutrition. The audit will also consider whether 
the tool is quick and easy to use. 
 
Why have I been chosen? 
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You have been  chosen because you have been  receiving haemodialysis  treatment 
for more than 3 months.   
 
Do I have to take part? 
It is up to you to decide whether or not to take part.  If you decide to take part you 
will be given this information sheet to keep and asked to sign a consent form.  You 
can nominate a carer to ask any questions and to take part on your behalf.  Please 
discuss your preference with the person providing the tool or the sister on the unit 
(Sarah Simpson) or the researching dietitian (Kim Bowra). 
If you decide to take part you are free to withdraw at any time and without giving a 
reason.  A decision to withdraw or not to take part will not affect you in any way.   
 
What will happen to me if I take part? 
 You will be approached by a clinical support worker on dialysis to answer 4 
questions from the LTHT screening tool; about your weight, eating, appetite 
and physical appearance.  This will take about 10 minutes.  A further 2 
questions will then be completed by the staff member by using the computer 
system, to consider your weight and any recent weight loss.  The LTHT 
screening tool is to be tested whilst you are on dialysis, as this is where the 
tool will be used eventually, just like other nursing care tools.  You can have 
the curtain pulled around or you can complete the questions before or after 
dialysis if you prefer.  Please indicate your preference.  
 Some patients may be asked to complete the LTHT screening tool twice; once 
with the clinical support worker and once by yourself or with a nurse.  This 
will be discussed with you at the beginning.   
 You may also be asked to give some feedback on the LTHT screening tool by 
completing a feedback questionnaire, but this will be discussed with you.  The 
questionnaire consists of 7 questions and will take about 15 minutes.  The 
questionnaire can be completed by yourself alongside your carer, the nurse or 
clinical support worker, or on your own. 
 
What will happen with my answers? 
 The results of the LTHT screening tool will be compared with the dietetic 
clinical judgement results to see how accurate the screening tool is at 
identifying if you are at risk of malnutrition or if you are not at risk of 
malnutrition.  
0300006 
 
  94
 Dietetic clinical judgement scores will be created by one dietitian, looking at 
notes of previous dietetic assessments and at the computer system, which is 
accessed as part of routine practice.  If there is not enough information 
available, permission may be asked for the dietitian to gather this information 
from you in person.  
 The feedback questionnaires will be collated to consider whether the 
screening tool needs any future improvements. 
 
What if I am at risk of malnutrition? 
 A referral to the dietitian for dietary assessment will be automatically 
generated if the dietetic clinical judgement method feels that you are at risk 
of malnutrition, regardless of the results of the LTHT screening tool, as the 
screening tool may not be accurate.  
 If the LTHT screening tool results suggest that you are at risk of malnutrition, 
this will be checked against the dietetic clinical judgement results.  As above, 
if you are deemed to be at risk of malnutrition by the dietetic clinical 
judgement method a referral will be automatically triggered.  If however, the 
dietetic clinical judgement results suggest that you are not at clinical risk of 
malnutrition, a referral to the dietitian will not be generated. 
 You can ask for the LTHT screening tool and the dietetic clinical judgement 
results.  On request the dietitian will check the results of both and feedback to 
you within 10 working days.   
 If you feel that a dietetic referral is required regardless of the audit results you 
can request to discuss this with the dietitian and a dietetic referral can then 
be considered together if necessary. 
 If you are offered an appointment with the dietitian, you can accept or 
decline a referral to the dietitians.  
 If you accept, the dietitian will then assess you within 2 weeks.  The dietitian 
will update your doctor with any relevant information, as they would in 
routine practice.   
 
What are the possible disadvantages and risks of taking part? 
There are no known risks involved and it is hoped that any inconvenience to yourself 
will be limited.  It is hoped that you will not find any of the questions to be of a 
sensitive nature or that any embarrassment is experienced.  If you do not wish to 
answer any of the questions asked you can simply decline. 
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What are the possible advantages of being involved? 
Your involvement will be of great worth for the development of an effective 
nutritional screening tool.  The data will be analysed and depending on the results, 
the LTHT screening tool may be put into routine practice.  The tool may need further 
modifying and auditing.  If the tool is implemented it is hoped that future patient 
care will be further improved and that the tool will help you to become more aware 
of your risk of malnutrition. 
 
Will my taking part in the study be kept confidential? 
All information will be kept confidentially and data protection regulations will be 
followed for processing, storage and destruction.  The information will be kept as 
per the NHS retention policy.  Only staff working on the audit will have access to the 
data. There are no conflicts of interest.   
 
What happens with the results of the study? 
The results will be written up as part of an MSc project.  Individuals who participate 
will not be identified in any subsequent report or publication. 
 
Who is organising the research? 
The research is conducted as part of a Masters qualification in Nutrition and 
Dietetics, within the Faculty of Life Sciences at the University of Chester.  The study 
is organised by Kim Bowra, an MSc student.  The Leeds Teaching Hospitals Trust is 
covering the majority of costs. 
 
What if I have a question or a complaint? 
There will be time for discussion and questions throughout the study.  If there are 
any concerns that you may have you can contact the dietitian (Kim Bowra 0113 
2065886) or the sister of the unit (Sarah Simpson).  If you wish to complain to the 
university, please contact Professor Sarah Andrew, Dean of the Faculty of Life 
Sciences, University of Chester, Parkgate Road, Chester, CH1 4BJ, 01244  513055. 
 
Thankyou for your interest. 
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Appendix 6. Consent form 
                       
                                             
                                                         
If you are happy with the information provided please sign below and agree 
your consent to take part. 
 
Title of Project:  
An audit to test if the LTHT nutritional screening tool can identify haemodialysis 
patients at risk of malnutrition. 
 
Name of Researcher: Kim Bowra 
     Please initial box 
 
1. I confirm that I have read and understand  
the information sheet for the above study  
and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary  
    and that I am free to withdraw at any time, without  
    giving any reason and without my legal rights being  
    affected. 
 
3. I agree to take part in the above study.   
 
 
4. I would like to nominate a carer          Y/N 
 
Carers name…………………     Carers signature……………… 
 
___________________      _________________   _____________ 
Name of Participant Date  Signature 
 
 
Researcher Date Signature
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Appendix 7. Sample size calculations 
 Sample size calculation used within this study 
The sample size calculation, taken from Jones (2004a, p 300) was specifically designed for the 
development of a NST, such as LST,  using multivariate analysis, in which each variable is tested in 
order to consider the most effective tool. 
  
= 1000x number of risk variables/ percentage prevalence of malnutrition = patient  
required 
 
= 1000x 6 (varaibles in LST)/43% (based on previous small scale audits, see  Appendix 
1) 
n = 139 patients. 
This is a realistic and feasible number, due to research funding obtained for the collation of data for 
the dependent variable. 
Consider a 1% decline in participation and 0% dropout, based results from previous audit results 
(see Appendix 1).  This was however a low figure and from clinical observation participants are 
frequently not available; admitted to hospital, receive transplants and pass away and therefore this 
sample number is the lowest minimum sample number to aim for.  
 
 Other sample size considerations 
Sensitivity and specificity power calculations were also considered (based on work by Jones, 
2004b, p 315), as a fundamental consideration of testing NST accuracy, however these calculations 
produced figures that were not clinically feasible, n = 245 at a level of 80% sensitivity and 
specificity (as illustrated below).  80% is the figure set from literature appraisal and illustrated 
within Marian et al. (2013) and Weekes et al. (2004).  
N A = 1.962x80 (100-80) 
             52 
N = 245 
 
 
Calculation of reliability, as another key element of NST testing, also provided an unachievable 
sample number of n = 387 (Jones, 2004c, p 309), based on the unknown previous estimates 
available for other raters and Cantor’s method.   
 
N = 139 was a realistic number to achieve and allows for appropriate statistical analysis. Sensitivity, 
specificity and reliability could also be analysed within this number, as a fundamental part of 
analysis, albeit to a lesser extent. 
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Appendix 8- Training package for researchers 
 
1
The LTHT Nutritional 
Screening Tool
Kim Bowra
Renal dietitian
     2
Content
 Background
 Why screen for malnutrition?
 Previous audit results
 LTHT screening tool 
 The study; recruitment, PIS, consent, the protocol
 LTHT Research guidance document; 
confidentiality, data protection and information 
governance
 Future implementation of the screening tool
 
3
Guidelines, Recommendations and Campaigns
     4
Definition of Malnutrition
 NICE guidance 2006 describes malnutrition as:-
“ a state in which a deficiency of nutrients such as energy, 
protein, vitamins and minerals causes measurable adverse 
effects on tissue composition, function or clinical outcome.”
 The Renal Association (2010), quotes;
 NICE (2006) classification of a patient being at risk of 
malnutrition if they fall into any of these categories:
 A body mass index (BMI) < 18.5 kg/m²
 Unintentional weight loss >10% over the past 6 months
 A BMI <20kg/m² and unintentional weight loss >5 % over the last 
6 months.
 
5
What is the impact of 
malnutrition?
      6
Why may patients struggle 
with their eating?
Restrictive 
diet
Time away 
from home
Effects of 
dialysis
Mood/
depression
Some 
patients 
may not be 
able to eat 
on the 
machine
Missing  
meals due 
to dialysis
Other co-
morbidities 
and health 
worries
Social issues
Poor dialysis 
clearance-
may cause 
uraemia and 
fluid overload
Position on 
the 
machine
medication
Inconsistent 
advice from 
health care 
professionals
                 
7
Development of the renal screening 
tool
 4 small scale audits to date
 Some patient and nursing involvement and 
feedback
 Renal dietetic team feedback
 Patient language group feedback
 Need to test in a bigger number and with 
the intended users
      8
The LTHT Nutritional Screening tool 
for audit 
 
0300006 
 
  99
19
The first step in the audit
 Ethical considerations
 Read and understand the principles of 
confidentiality, data protection and 
information governance- see the LTHT 
research guidance notes.
 Gaining patient consent- PIS and consent 
form
 Free to withdraw
   10
Limiting bias
 4 subjective questions to be answered first-
with the patient
 Then 2 objective questions- at the 
computer
 Standard technique, see the 5 step guide.
 Ask the question, listen to the response, 
use their answer as a guide in completing 
the answers on the tool.  Repeat the 
answer that you feel best suits what they 
have said so that they can clarify.
 If you are still unsure read all of the 
possible answers to the patient and they 
can decide
 If you remain unsure or feel this does not 
match your judgement then leave blank.
11
Questions to be asked
 Use your judgement alongside patient 
answers
 A- unintentional weight loss, amounts, time 
frames and medical changes 
 B and C- intake and appetite are 2 different 
entities. Listen for amounts, frequency and 
timeframes.
 There may be no change, but this does not 
mean the intake is sufficient.
 Possible warning signs are:
‘My dentures 
are too loose’
‘I’ve been feeling 
under the weather 
for a couple of 
weeks’
Noticeable change in mood, 
‘I’m struggling with the 
cooking at the 
moment’
   12
Question D
 Physical appearance may be challenging for the patient 
or user to identify.
 It is essential that this is considered jointly
 Patients that look slim, may not be malnourished.
Question: Who do you think is at risk of malnutrition? 
 
Answer: Anyone could be at risk. It’s not a matter of 
shape and size !    
13
Some guidance
   14
Question E and F
 Consider the most appropriate weight 
to use- TW, influenced by BCM results
 Is the weight history accurate? Or is it 
biased by previous fluid overload and 
therefore does not reflect flesh weight 
change?
15
The Nutritional care plan
 The importance of creating an average
 Documentation, see the data collection proforma
 Where appropriate dietetic referral may be 
indicated
  16
Feedback
 Non-validated semi-
structured 
questionnaires
 Audit analysis by the 
dietitian
 Questions???
 
Handout 1‐  The Leeds Teaching Hospitals NHS Trust, Research & Development Department 
‘DATA PROTECTION IN RESEARCH’. 
Retrieved from;  
http://www.leedsth.nhs.uk/fileadmin/Documents/Academic/Research/Documents/RESEARC
H_PROPOSAL/DataProtectioninResearchGuidance.pdf  
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Appendix 8. Researcher standardised protocol - Handout 2 
 
Discussion points 
 Introduction to the patient information sheet and consent sheet 
 The patient population are all deemed to be vulnerable due to their diagnosis and the 
hospital setting- A carer can be nominated by the patient to ask and answer questions. 
 
 Which objective measures will I need? 
 Patient height and weight measurements are a routine part of dialysis prescription, with 
patients wearing indoor clothing and without shoes.   
 Height is measured on initiating HD and on clinical need, with the patient’s feet flat on the 
base plate, with no shoes on and the body straight against the wall, a reading is taken as 
the head-plate touches the head.  If the patient is unable to be heighted self-reported height 
is documented.   
 Weights are taken before and after each dialysis session, using calibrated standard stand 
on scales and wheelchair scales.  The pre and post HD weights, alongside 3 monthly 
bioelectrical impediance measures and clinical judgement, are reviewed by renal N/S at 
each HD session and inform the target weight.   
 
 The computer system provides these objective measures  
 Both measures are inputted to the computer system after each HD session, which 
calculates up-to-date BMI scores and percentage weight loss, using target weight.   
 
 What if the patient asks for their results? 
The patient will not be given the results of the LTHT tool routinely, but they can ask for the 
results of the tool.  Equally the patient can ask for the results of the clinical judgement 
method (the criterion measure).   
If the patient requests the results of either method, you need to explain the following; 
The results of the screening tool will be checked by a dietitian, as they may not be accurate 
and they will come and feedback the results from the screening tool that you completed, as 
well as the results from what the dietitian has assessed.  This will happen within 10 working 
days. 
 
 What happens then?  What if the patient is highlighted to be at risk of malnutrition? 
Only if the patient is highlighted to be at risk of malnutrition, based on the criterion method 
of dietetic clinical judgement, they will be routinely offered an appointment for a dietetic 
assessment, where support can be provided.  The assessment will be done independently 
of the lead researching dietitian.   
If the patient is not deemed to be at risk by the criterion method, this will be discussed with 
them by the independent dietitian and a dietetic assessment will only be offered if the 
patient requests this.  
If the participant does not ask for the results of the tool but they are found to be at risk of 
malnutrition by the clinical judgement method the independent dietitian will offer the patient 
an appointment for dietetic assessment. 
The proforma in use to highlight this will be shown to you. 
 
 The researcher protocol- see Handout 3 
 
 Data proformas to be used and by who- show examples  
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Appendix 8. Researcher standardised protocol continued (Handout 3)- 
5 step guide for completing the nutritional screening tool 
1.  It is essential to gain patient consent before completing the screening tool 
‐In order to gain consent the patient needs to understand what they are consenting to  
  Ie/ A number of questions asking about their nutritional status, if this shows they are at risk of   
  malnutrition then they will be offered a referral to the dietitian 
‐ Circle consent Y for yes if the patient agrees to complete the tool 
‐ If the patient does not consent.  Circle N for No and plan to re‐screen in 3 months 
‐ Please complete your position, name and date to show who has gained consent from the patient 
 
2.  The nutritional screening tool has 4 questions that you can ask the patient.  Where possible you need to 
ask the patient questions  A to D 
‐ Ask the question outlined and listen to their response  
‐ Using their answers as a guide circle the score appropriate to their answer.  Use their answer alongside  
   your clinical judgement to decide on this score. 
‐ Read the answer to the patient that you feel fits with what the patient has said in order to clarify their  
   meaning and to ensure the appropriate score is given 
‐If the answer they provide falls between two of the answers outlined or you are unsure which score to  
  give read all of the answers, from 1 to 4 to the patient and then you can agree the appropriate score 
 
3.  There may be some questions which you feel cannot be asked‐ as the answers are unknown, unavailable or 
you feel you are not able to score due to lack of clarity from the patient.  It is important to answer as many 
questions as you can to make the score as appropriate as possible.  However a wrong answer will affect the 
results and so when unsure leave blank. 
Consider the illustrations below;   
 Question A and E‐ You may not know the extent of the recent ‘weight loss’ of the patient; 
‐ If they have come from another hospital and so we have no history available  
‐ If the patient does not know or cannot give an accurate recent weight history 
‐ If the patient is known to have been very fluid overloaded previously and so you feel the weights  
   available do not accurately consider flesh weight 
 Question D‐ You may find it difficult to grade a patients physical appearance.  
‐ Those patients that appear as slim or very slim may have been this way for a long time and are actually  
   not malnourished 
‐ Likewise in those that are very overweight any muscle and fat loss maybe be somewhat hidden 
‐ It is very important to ask the patient how they feel and using their answer consider alongside your  
  clinical judgement 
4.  When considering BMI and weight change we need to choose the most reliable weight available 
‐The most accurate weight is the target weight, informed by a BCM test 
‐ If you are concerned that a BCM has not been completed in a timely way, this can be requested 
‐ On considering the appropriate score for weight change we must only consider unintentional weight  
  loss and so it is important to emphasise this to the patient as per question A 
 
 
5.  For the scores to make sense we need to create an average.  This is done adding the scores together and 
dividing the total by the number of questions asked 
‐  Consider a patient who does not speak English for example, only questions D, E & F can be answered 
‐  To generate an average, the answered questions need to have their scores added together.  In this    
    example scores of 2+3+4 were generated = 9 as a total score.  9 (total score) divided by 3 (questions)  
    provides the average score of 3 
 
 
The score is important so that the referrals can be triaged appropriately and priority patients noted.  The 
action required should match your clinical judgement.  If a referral is required remember the patient needs to 
consent to this process and then a referral form can be faxed to the dietetic department.  There may be other 
reasons for a dietetic referral; diabetes, renal dietary advice, weight management for example. 
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Appendix 8. Methodological detail linking to Section 3.32 and Figure 3.1 
Study procedure detail.  
Those in step 1a and those in step 3 formed part of the reliability testing, whereby both sets 
of results were then independently compared to the results generated by the CSW, at a later stage.  
The N/S identified those patients that were known to be able to self-complete for step 1a, as 
14 consecutive patients on the computer report (consistent with Cawood et al., 2012), albeit one 
patient declined.  The N/S did not screen any of the self-completion patient group and so this helped 
to eliminate procedural bias.  All of the patients in step 1a completed the subjective questions (A to 
D) and then a questionnaire.  The objective questions were completed by the independent dietitian.     
Within 7 days, the CSW screened the patient in step 1b.  All patients in step 2 were 
screened by the CSW and every 9th patient on the list completed a semi-structured questionnaire(n = 
16).  The CSW completed a questionnaire biweekly (n = 4), based on their experience in using the 
LST. 
The CSW, in step 3, identified 4 patients per week, as every 7th patient on the computer 
report, for the N/S to screen within 7 days of CSW screening (to a total of 14).  The nurse 
completed the NS and then completed a semi-structured questionnaire (Appendix 4). 
In step 4, the researching dietitian was instructed by the CSW to complete the criterion 
measure, whereby on a weekly basis a list of patient numbers was provided, for those who had 
consented and completed the LST (in step 1b, 2 and 3).  Creating the criterion measure after the 
independent variable, may limit bias as the patient may be less aware of their nutritional status at 
this time than those that are being assessed by the dietitian. 
Data collection  
An independent dietitian located results from each step and transfered to one proforma. 
None of the patients asked for their results and so the independent dietitian was not required to 
approach the patients for this purpose.  Data was not compared by the researching dietitian until the 
all data had been collected. 
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Appendix 9. Non-Validated questionnaires 
Clinical support worker and nurse semi-structured questionnaire.  
Date…………… 
 
Thank you for using the nutritional screening tool with the patients 
Please consider the following 6 questions, based on your experience of using the 
nutritional screening tool; the way the questions were asked, the questions themselves and 
any thoughts or feelings you may have which we can use to improve the tool. 
Please circle the answers below and provide comments and suggestions where indicated. 
Name     ………………………………… 
Questions 
1. Do you feel that the reason for using the screening tool is clearly understood by the patients?  
Yes/No and suggestions 
  
 
 
 
 
2. Do you feel the patients clearly understood the questions asked?  
Yes/No and suggestions 
 
 
 
 
 
3. Do you feel the suggested answers captured the patients answers?  
Yes/No and suggestions 
 
 
 
 
 
4. Do you have any comments with regards to appearance of the tool?  
Yes/No and suggestions 
 
 
 
 
 
5. Do you have any comments with regards to the practicalities of using the tool? 
Yes/No and suggestions 
 
 
 
 
 
6. Further comments 
 
 
 
 
Thank you for completing this feedback.  
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Appendix 9. Patient questionnaire 
Date…………………. 
 
Thank you for completing the nutritional screening tool 
We would now like to ask you if you have any feedback about the tool; the way 
the questions were asked, the questions themselves and any thoughts or 
feelings you may have which we can use to improve the tool. 
Please complete your name below or equally you can complete the feedback 
without leaving your name.  
                          Name     ………………………………… 
There are 7 questions about the nutritional screening tool listed. You can 
complete this whilst on dialysis, after dialysis or at home.  You can complete this 
by yourself, with a carer, a nurse or clinical support worker reading and writing 
your answers down for you.       
               Please advise which is most suitable to you. 
 
Questions 
1. Do you feel that the reason for using the screening tool has been clearly explained 
to you?  
Yes/No and suggestions 
 
 
 
 
2. Do you feel the questions asked were clear in their meaning?  
Yes/No and suggestions 
 
 
 
 
3. Do you feel the answers available captured what you wanted to say? 
Yes/No and suggestions 
 
 
 
 
4. If you completed the tool yourself, do you have any comments with about the 
appearance of the tool?  
Yes/No and suggestions 
 
 
 
5. Do you feel that the screening tool results agree with how you feel about your risk of 
malnutrition?  
Yes/No and suggestions 
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6. Do you have any comments with how the tool was used in practice? 
Yes/No and suggestions 
 
 
 
 
7. Further comments 
 
 
 
 
Thank you for completing this feedback.   
We welcome any positive comments and any suggested improvements.  The 
information you have provided will be used to better the nutritional screening 
tool so that in the future we hope to use a tool that has been developed 
alongside patients receiving haemodialysis treatment. 
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Appendix 10. Statistical testing, links with section 4.1 
 
Correlation of risk variables with risk of malnutrition (links to 4.2) 
 
 
 
 
Multivariate analysis- Multiple regression (links with 4.4.4) 
 
Stepwise analysis 
shows model 4 has 
the highest R value 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model Summarye 
Model R R Square Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .781a .611 .607 .556
2 .845b .715 .710 .478
3 .893c .797 .792 .405
4 .903d .815 .809 .388
a. Predictors: (Constant), F 
b. Predictors: (Constant), F, E 
c. Predictors: (Constant), F, E, B 
d. Predictors: (Constant), F, E, B, D 
e. Dependent Variable: Dietitian 
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Multiple regression continued 
 
 
Scatter diagrams for objective data (links to 4.4.4) 
Note Green = at risk and blue = not at risk 
             
 
                                Weight loss (variable F) 
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Agrees with anticipated results in that those at risk (in green) should be in position 3 and 4 on the X 
axis and those in blue in position 1 or 2. 
 
 
 
 
Scatter diagrams for subjective variables 
 
     
   
Subjective weight change (variable A) 
It would be anticipated that those at risk (green) would be closer to 3 and 4 and blue (not at risk) 
would be in position 1 and 2 of the X axis. 
 
Eligible participants that failed to complete (links with 5.3)  
Reasons and 
numbers of 
attrition 
Age BMI  Weight change  Diabetes More than 1 Co-
morbidity * 
Median 
(years) 
range Median 
(Kg/m2) 
range Median 
(%) 
range Yes 
 (n) 
No 
 (n) 
Yes 
 (n) 
No 
 (n) 
In hospital (n = 3) 81 70.4-
89.3 
27.1 19.6-
29.9 
1.5 0-2 2/3 1/3 3/3 0/3 
Received a 
transplant (n = 3) 
45.9 29.4-
53.8 
28 23.6-
33.9 
0 0-1.2 0/3 3/3 0/3 3/3 
RIP (n = 7) 74.1 13.1 22.7 3.3 1.2 2.2 1/3 2/3 1/3 1/3 
Declined  
(n = 3) 
76 48.7-
89.3 
22.05 19.6-
27.2 
0.7 0-5.3 2/8 6/8 5/8 3/8 
Total (n = 16) 71.1 29.2-
89.3 
28.5 19.6-
35.5 
0 0-5.3 5/16 11/16 9/16 7/16 
Note.*including emphysema, diabetes, malignancy and liver disease 
Characteristics of those that did not complete remained similar to those that completed (Table 3.3). 
